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Summary 
Plasmodium falciparum is one of the most deadly malaria parasites and causes 
the tropical disease “malaria tropica”. Most of the pathology can be explained by 
the drastic host cell modifications which are initiated by the parasite shortly after 
invasion. Moreover, upon the invasion of the mature human erythrocyte, the 
parasite encases itself with a parasitophorous vacuole (PV). It is known that the 
parasite exports 300-400 proteins to the host cell, to change the biophysical 
properties of the infected erythrocytes. However, up to date little is known about 
how the parasite sets up its own protein export machinery in a host cell devoid of 
any infrastructure. Scientific knowledge was significantly boosted with the 
discovery that ATP, a factor in the host cell cytoplasm and protein unfolding was 
pivotal to protein export across the PV membrane (PVM). Further, the discovery 
of the parasite-encoded protein translocon called PTEX (Plasmodium Translocon 
of EXported proteins) in the PVM shed more light on the underlying mechanism. 
In 2016, data was obtained that the human heat-shock protein 70 (HsHsp70) is 
essential for the transport across the PVM. Based on this observation, this study 
focussed on the question whether HsHsp70 is vital to the parasite’s intra-
erythrocytic development. For this purpose, a resealing approach commonly used 
in pharmacology was established. Since the mature human erythrocyte cannot be 
easily genetically modified, the resealing approach was used to achieve a classic 
dominant negative effect by pre-loading the mature human erythrocytes with an 
excess amount of mutated recombinant HsHsp70. Afterwards the resealed 
erythrocytes were infected with P. falciparum parasites. Interestingly, the growth 
was not altered by the presence of the excess amount of the mutated HsHsp70. 
In addition, the protein export in the presence of the mutant protein was analysed 
using parasites encoding green fluorescently labelled, known exported, proteins. 
Surprisingly, the protein transport was not inhibited by the presence of the 
mutant, as well. Last, parasites depleted of a parasite-exported Hsp70 called 
Hsp70x, were used to infect the resealed cells pre-loaded with the mutated 
protein. The growth and protein export were not altered for the ∆Hsp70x parasite. 
In conclusion, under the given experimental setup, no essential function of 
HsHsp70 for the growth and protein export of P. falciparum was revealed.   
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Zusammenfassung 
Plasmodium falciparum ist einer der tödlichsten Malariaerreger und führt zur 
Tropenkrankheit „Malaria Tropica“. Der Großteil der Pathologie geht mit den 
drastischen Wirtszellmodifikationen, welche direkt nach der Invasion vom 
Parasiten induziert werden, einher. Zudem schließt sich der Parasit während der 
Invasion der Wirtszelle, dem reifen humanen Erythrozyten, in eine parasitophore 
Vakuole (PV) ein. Der Parasit exportiert 300-400 Proteine in die Wirtszelle und 
verändert dabei die biophysikalischen Merkmale der Wirtszelle. Dennoch ist bis 
heute nicht bekannt wie der Parasit eine Protein-Export-Maschinerie in eine 
Wirtszelle ohne jegliche Infrastruktur integriert. Unser Wissen konnte durch die 
Entdeckung, dass ATP, ein zytoplasmatischer Wirtszellfaktor und 
Proteinentfaltung entscheidend für den Transport über die PVM sind, erweitert 
werden. Die Entdeckung des PTEX-Translokons (Plasmodium Translocon of 
EXported proteins) in der PVM konnte mehr Licht auf die Mechanismen werfen. 
Im Jahr 2016 konnten Experimente eine essentielle Rolle des humanen 
Hitzeschock Proteins 70 (HsHsp70) im Protein-transport über die PVM nach-
weisen. Basierend darauf, wurde hier untersucht, ob HsHsp70 überlebenswichtig 
für die intra-erythrozitäre Entwicklung des Parasiten ist. Dazu wurde eine in der 
Pharmazie verwendete „Resealing“ Methode etabliert. Da der reife Erythrozyt 
sich nicht leicht genetisch manipulieren lässt, wurde durch das „Resealing“ ein 
klassisch dominant negatives Vorgehen ausgewählt, bei dem der Erythrozyt mit 
einem Überschuss eines mutierten Hsp70s beladen wird. Dann wurden die 
„resealten“ Erythrozyten mit P. falciparum infiziert. Interessanterweise wurde das 
Wachstum durch den Überschuss des mutierten HsHsp70s nicht beeinflusst. 
Auch der Proteinexport in Anwesenheit des mutierten HsHsp70s mit Parasiten, 
die grün-fluoreszierende exportierte Proteine exprimieren, zeigte keine 
Einschränkungen durch die Präsenz des mutierten HsHsp70s. Zuletzt wurden 
mutierte Parasiten ohne parasitäres exportiertes Hsp70, Hsp70x, für die Infektion 
von „resealten“ Erythrozyten verwendet. Das Wachstum und der Proteinexport 
der ∆Hsp70x Parasiten wurden durch die Anwesenheit der Mutante nicht 
verändert. Unter diesen experimentellen Voraussetzungen konnte keine 
essentielle Funktion des HspHsp70 für das Wachstum und den Transport von P. 
falciparum enthüllt werden.                         . 
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1 Introduction 
1.1 Introduction into Malaria 
The subtropical and tropical disease malaria is caused by the obligate 
intracellular parasite genus Plasmodium. The disease was already described in 
1880 by the French military surgeon Alphonse Laveran (Nye, 2002). Today, more 
than 100 Plasmodium species are known, including 5 that are pathogenic to 
humans: Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, the 
recently identified simian agent Plasmodium knowlesi, and Plasmodium 
falciparum, causing the most severe and deadly form called malaria tropica 
(Cowman et al., 2016; Phillips et al., 2017). Despite the greatest efforts by the 
world health organisation (WHO), 219 million malaria cases were reported in 
2017, of these 435,000 people did not survive the disease (WHO, 2018). The 
most deadly Plasmodium parasite represents Plasmodium falciparum, which 
accounted for 99.7% of the reported deaths in 2017 (WHO, 2018). Particularly, 
children under the age of 5 and pregnant women in malaria endemic regions 
such as Africa, South-East Asia and Latin America are at high risk for fatal 
malaria (Figure 1). The WHO recommends an Artemisinin-based combination 
therapy (WHO, 2018), but growing drug resistances make it hard to treat the 
disease and emphasise the need for the identification of new drug targets (Wells 
et al., 2015).  
 
Figure 1 Comparison of the malaria cases in endemic areas in 2000 and their status in 2017. 
Most of the malaria cases were still reported in Latin America, Africa and South-East-Asia (modified from the 
Malaria Report, WHO 2018). 
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1.1.1 Life cycle of Plasmodium falciparum 
The complex life cycle of Plasmodium falciparum can be divided into an asexual 
multiplication, occurring in the mammalian host, and a sexual multiplication taking 
place in the invertebrate host (Cowman et al., 2016). The asexual multiplication 
can be further divided into an exo-erythrocytic phase referred to as liver stages 
and an intra-erythrocytic known as blood stages (Figure 2).  
 
Figure 2 Life cycle of Plasmodium falciparum  
The infection is initiated by an infected female Anopheles mosquito taking a blood meal from a human. 
Sporozoites are released and actively invade the hepatocytes, starting the exo-erythrocytic phase. After 1-2 
weeks, merozoites are released and start the asexual blood cycle. Some merozoites become sexually 
committed and develop into mature female and male gametocytes which are able to infect a mosquito. In the 
mosquito, gametogenesis and fertilizations take place. Finally, a zygote is formed that develops into a motile 
ookinete, which breaks through the midgut epithelium and matures to an oocyst. The oocyst releases 
sporozoites that accumulate in the salivary glands of the mosquito (modified from Su et al. 2007). 
 
A malaria infection starts with an infected Anopheles mosquito taking a blood 
meal from a human. During the blood meal sporozoites are released into the host 
dermis. The sporozoite actively migrates through the skin until it hits a blood 
vessel, which transports the parasite passively to the liver. In the liver, the 
sporozoite passes through endothelial cells, Kupffer cells (macrophage-like cells), 
and several hepatocytes before finally invading a liver cell (Tavares et al. 2013, 
Mota et al. 2001). Up to 2 weeks later, the sporozoite matures into a liver 
schizont (Amino et al., 2007). Then, merosomes are released into the blood 
stream and burst to discharge up to 40,000 merozoites (Sturm et al., 2006), 
marking the beginning of the intra-erythrocytic cycle. The merozoite actively 
invades the human erythrocyte by making use of its apical complex (complex of 
rhoptries, micronemes, apical polar ring and coniod) (Blackman and Bannister 
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2001). Upon the invasion of the host cell, the parasite encloses itself with a 
parasitophorous vacuole membrane (PVM), thereby separating itself from the 
host cytosol (Lingelbach and Joiner, 1998). Shortly after, parasitic development 
continues with the ring stage. Already in the ring stage the parasite starts to 
remodel its host cell by exporting parasite-encoded proteins to the erythrocyte 
cytosol (Das et al., 2015; Spielmann et al., 2006). 20-24 h post-invasion, the 
parasite progresses to the trophozoite stage in which more drastic host cell 
modifications are introduced (Cowman et al., 2016). One of the most striking 
modifications are small protrusions on the surface of the host cell known as 
knobs. On top of the knobs, the major virulence factor EMP1 (Erythrocyte 
Membrane Protein 1) is presented, which drastically changes the biophysical 
behaviour of the erythrocyte (Cowman et al., 2016; Phillips et al., 2017). The 
exact mechanisms of protein export and the thereby induced host cell 
modifications will be discussed in more detail in 1.2. The trophozoite develops 
into a schizont containing 16-32 merozoites (Cowman et al., 2016). During the 
intra-erythrocytic development, the parasite uses the host haemoglobin as a 
nutritional source and converts the accumulating toxic heme into hemozoin 
crystals (Slater and Cerami, 1992; Slater et al., 1991). Finally, the schizont and 
infected erythrocyte rupture, resulting in the release of mature merozoites into the 
blood stream. This step includes the release of hemozoin and pyrogens 
associated with the typical fever observed in malaria patients. After some rounds 
of asexual multiplication, some merozoites become sexually committed with a 
female bias (Silvestrini et al., 2000). In a process called gametocytogenesis, 
encompassing five stages (I-V), the parasite undergoes radical morphological 
changes resulting in a mature stage V male microgametocyte and female 
macrogametocyte. The mature stage V gametocytes are the only stage able to 
transmit the disease to a mosquito (Greenwood et al., 2008). Stage V 
gametocytes are taken up by the mosquito with a blood meal. The drop in 
temperature, the increased pH and the presence of xanthurenic acid in the 
midgut induce a process called gametogenesis (Billker et al., 1998; Garcia et al., 
1998; Sinden et al., 1996; Sinden et al., 1983). The macrogametocyte starts to 
round up, becoming a macrogamete, while the microgametocyte differentiates 
into 8 mobile microgametes (Pradel, 2007). The fertilisation of a macrogamete 
with a microgamete resulting in a zygote completes the sexual development. 
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After 24 h, the zygote develops into an ookinete, which traverses the midgut 
epithelium. Finally, the ookinete matures to an oocyst that resides between the 
midgut epithelium and the basal laminal. After 10-12 days, the oocyst releases 
thousands of sporozoites, which accumulate in the salivary glands of the 
mosquito (Dimopoulos et al., 1998). Once the mosquito takes a blood meal from 
a human host, the life cycle starts anew.  
 
1.2 Host cell modifications 
Shortly after invading, the parasite starts to make it comfortable in its new home, 
the mature human erythrocyte. Already 8-12 h post-invasion, the parasite 
increases the erythrocyte’s membrane permeability (Ginsburg et al., 1985; Kirk et 
al., 1994; Staines et al., 2000) by inducing Novel Permeation Pathways (NPP) 
(Baumeister et al., 2003, 2006; Kirk et al., 1999), thereby importing nutrients like 
sugars or amino acids, which the parasite cannot produce itself. The foundation 
for more drastic renovating events in the trophozoite stage is already laid in the 
ring stage. The parasite starts to export SBP1 (Skeleton-Binding Protein 1) 
(Blisnick et al., 2000) and MAHRP (Membrane-Associated Histidine-Rich Protein) 
(Spycher et al., 2003), 2 important components of the Maurer’s clefts. The 
Maurer’s clefts are an exomembrane structure directly underneath the 
erythrocyte membrane (Grüring et al., 2012; Lanzer et al., 2006).  
In the trophozoite stage, an extremely active phase of protein export and severe 
host cell alteration is started. In the beginning, the parasite is restructured to the 
needs of this phase by increasing the size of the Endoplasmic Reticulum (ER) 
(Bannister et al., 2000), the centre of protein biosynthesis. One of the most 
striking modifications induced during this phase are small electron dense 
protrusions on the erythrocyte membrane, the so-called knobs (Gruenberg et al., 
1983). On top of the knobs one of the most studied malaria proteins, EMP1 is 
presented (Figure 2) (Cowman et al., 2016; Przyborski et al., 2016). The already 
established Maurer’s clefts are vital to EMP1 transport and presentation on the 
erythrocyte. EMP1 is encoded by members of the multigene family referred to as 
var genes (Su et al., 1995). With the help of the var genes, the parasite is able to 
undergo antigenic variation, thereby successfully evading the host immune 
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system (Baruch et al., 1995; Su et al., 1995). Moreover, EMP1 presentation on 
the erythrocyte surface allows the parasite to bind to host cell ligands like ICAM-1 
(InterCellular Adhesion Molecule 1) and CD36 (Cluster of Differentiation 36) 
mediating cytoadherence (Smith et al., 1995). In the placenta, the EMP1 variant 
VAR2CSA enables the parasite to adhere to CSA (Chondroitin Sulfate A), thus 
harming the mother as well as the unborn child (Clausen et al., 2012; Salanti et 
al., 2004, 2003). Additionally, the infected red blood cell (iRBC) can bind to non-
infected erythrocytes in a process known as rosetting, shielding the infected cell 
further from the immune system. Both processes, rosetting and cytoadherence, 
contribute to the disease’s severity. As a result, small blood vessels are blocked, 
causing hypoxia and death by organ failures (Miller et al., 2002) (Figure 3).  
 
Figure 3 Rosetting and cytoadherence of P. falciparum infected erythrocyte 
Top: In trophozoite stage, the drastic host cell modifications become obvious. These changes include small 
protrusions, the so-called knobs, as well as EMP1 presentation on the surface of the infected RBC. 
Bottom: After host cell remodelling, the parasite is able to shield itself from the immune system by binding to 
non-infected RBC, a phenomenon known as rosetting. Further, the parasite avoids splenic clearance by 
binding to the host endothelium using the interaction between EMP1 and host ligands, resulting in 
cytoadherence. Both processes lead to a blockage of the vascular endothelium. P: Parasite, PV: 
Parasitophorous Vacuole, RBC: Red Blood Cell, K: Knob, EMP1: Erythrocyte Membrane Protein 1, (adapted 
from Yam et al. 2017). 
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An important prerequisite of all these modifications is the establishment of a 
protein export machinery introduced to the host cell by the parasite. To 
understand this complex process in more detail, a deeper knowledge of the host 
cell is required reviewed in the following.  
 
1.2.1 The host cell 
The human erythrocyte is commonly known as the major oxygen and carbon 
dioxide carrier. The gases are bound by the most abundant protein in the 
erythrocyte called haemoglobin, which is responsible for the typical red colour 
(Longeville and Stingaciu, 2017). Apart from this, erythrocytes are also 
associated with the transport of GPI-linked proteins (Kooyman et al., 1995) and 
iC3b/CBP (complement immune complexes) (Schifferli and Taylor, 1989). A 
proteomic study conducted by Pasini and colleagues found 340 membrane and 
cytoskeleton proteins in the erythrocyte (Pasini et al., 2006). Amongst these, 
most might be associated with the typical discoid shape of the cell. Additional 252 
soluble proteins were revealed. Most of these proteins were involved in cellular 
metabolism, transport and the formation of protein complexes (Pasini et al., 
2006). Interestingly, the human erythrocyte also contains chaperones such as, 
the heat shock protein 70 (Hsp70), Hsp90, Hsp60 and the heat shock cognate 70 
(Hsc70) (D’Alessandro et al., 2010; Kakhniashvili et al., 2004; Pasini et al., 2006). 
In general, the erythrocyte is a fully differentiated and highly specialised cell. The 
mature human erythrocyte circulating in the peripheral blood went through some 
severe changes during its maturation. The cell lost most of the classical 
eukaryotic organelles e.g. the nucleus, mitochondria, ribosomes with ER, and the 
Golgi apparatus (Gronowicz et al., 1984). In consequence, the erythrocyte is 
devoid of any protein transport infrastructure. In summary, the human mature 
erythrocyte is a rather uncommon choice as host cell. With the aforementioned 
extreme host cell modifications in mind, it is fascinating how the parasite, without 
exploiting any host infrastructure, exports so many proteins to the host cell. The 
parasite even complicated transport by enclosing itself within a PV. In this way, 
the parasite needs to redress the PVM not only for protein export, but also for 
import of amino acids or sugars, it cannot produce.  
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1.3 Protein export to the human erythrocyte 
The survival and propagation of the parasite largely depends on the export of 
300-400 proteins to the human host cell (Hiller et al., 2004; Maier et al., 2009; 
Marti et al., 2004; Sargeant et al., 2006). Up to date, it is not completely resolved 
how the parasite assembles its own protein export machinery in a host cell 
devoid of any protein transport system. Nonetheless, it represents an outstanding 
drug target. Due to its parasite origin, drugs would specifically target the parasite 
and not harm the human host (Gilson et al., 2014). Yet, even better would be to 
target a human protein essential for this process, as the parasite can then not 
develop resistance. 
 
1.3.1 Signal peptide sequences in Plasmodium 
Usually proteins destined for export are marked by an N-terminal hydrophobic 
signal sequence and are transported to the ER (Wickham et al., 2001). Indeed, 
parasite proteins intended to be exported also encompass a distinct N-terminal 
RxLx/EDQ signal peptide sequence referred to as Plasmodium EXport ELement 
(PEXEL) or Host Targeting sequence (HT) (Hiller et al., 2004; Marti et al., 2004; 
Przyborski et al., 2005). The PEXEL motif undergoes several important 
modifications before it is ready for export. First, the ER-resident aspartyl 
protease, called plasmepsin V (Boddey and Cowman, 2013) cleaves off the 
arginine and lysine, leaving the xE/D/Q known as the mature PEXEL. Afterwards, 
the PEXEL motif is acetylated (Boddey et al., 2010; Chang et al., 2008). The 
processed proteins enter the secretory pathway and finally get secreted into the 
PV. Interestingly, not all exported proteins contain a PEXEL motif. The most 
extensively studied EMP1 does not have a PEXEL, representing an important 
member of the so called PEXEL-Negative Exported Proteins (PNEP) (Spielmann 
and Gilberger, 2010). The PNEP are characterised by the presence of an internal 
hydrophobic region, which is sufficient for entering the secretory pathway (Haase 
et al., 2009; Spielmann and Gillberger 2010).  
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1.3.2 How to reach the host cytoplasm? 
It was long debated how proteins end up in the host cell cytoplasm. Experimental 
data was pointing towards the existence of a translocon in the PVM. Major 
evidence was obtained by Ansorge and colleagues revealing that a protein 
source and ATP in the host cell are needed for transport across the PVM 
(Ansorge et al., 1996). Additionally, Gehde and associates showed that protein 
unfolding is required to pass the PVM (Gehde et al., 2009). Both studies were 
strongly supporting the so far hypothesised and long debated existence of a 
translocon (Charpian and Przyborski, 2008). Finally, in 2009 the debate came to 
an end due to the identification of the Plasmodium Translocon of EXported 
proteins, in short PTEX (de Koning-Ward et al., 2009).  
 
1.3.2.1 The Plasmodium Translocon of EXported proteins (PTEX) 
The PTEX translocon is a 1,200 kDa complex containing 5 core proteins. The 
pore in the PVM is produced by EXP2 (EXported Protein 2) (de Koning-Ward et 
al., 2009), which was recently found to be involved in the transport of nutrients 
(Garten et al., 2018), as well. Additional components are Hsp101 (Heat-shock 
protein 101), a known ClpB-type-AAA-ATPase most likely associated with the 
unfolding of the cargo protein, and thioredoxin 2 (Trx2) (de Koning-Ward et al., 
2009). Trx2 is probably involved in reducing disulfide bonds (de Koning-Ward et 
al., 2009). Finally, PTEX88 and PTEX150 complete the PTEX translocon and 
most likely perform structural tasks (de Koning-Ward et al., 2009). Recently, it 
was shown that both PNEP as well as PEXEL proteins use the translocon to 
redress the PVM (Elsworth et al., 2014; Grüring et al., 2012). Moreover, studies 
revealed that PTEX components such as PTEX150 and Hsp101 are produced 
during schizogony, emphasising the importance of PTEX (Bullen et al., 2012; 
Riglar et al., 2013).  
As previously mentioned proteins destined for export enter the secretory pathway 
and are released into the PV (1.3.1). The transport mediated by a translocon 
typically includes protein unfolding (Eilers and Schatz, 1986; Paunola et al., 1998; 
Walker et al., 1996). In consequence, after translocation the protein also needs to 
be refolded in order to fulfil its task in the host cell (Figure 4). 
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Figure 4 Overview of protein transport in the infected erythrocyte 
Proteins destined for transport enter secretory pathway and get secreted into the PV. In the PV, proteins 
require unfolding in order to redress PVM by assistance of the PTEX translocon. Once in the RBC cytosol, 
proteins need to be refolded. P: Parasite (blue), PV: Parasitophorous Vacuole (yellow), RBC cytosol: Red 
Blood Cell cytosol (red), PTEX translocon: orange: Hsp101, green: PTEX150, dark blue: EXP2 (adapted 
from Boddey and Cowman, 2013). 
 
The unfolding and refolding of proteins is usually performed by a highly 
conserved protein class known as chaperones (Eilers and Schatz, 1986; Paunola 
et al., 1998; Walker et al., 1996), reviewed in more detail in the following.  
 
1.4 Chaperones 
The nascent protein emerging from the ribosome requires folding, a task 
performed by so-called molecular chaperones (Gidalevitz et al., 2013). The highly 
conserved class of chaperones executes many jobs. Amongst these, chaperones 
are involved in protein translocation, resolve protein aggregates and assemble 
oligomers (Dekker et al., 2015; Goloubinoff, 2017). Molecular chaperones are 
crucial to the health of a cell and can be found in nearly all living cells (Lindquist, 
1986). The Heat-Shock-Proteins (Hsp) are a well characterised chaperone group 
(Saibil, 2013). The Hsps are synthesised in particular during stress such as 
febrile episodes (Javid et al., 2007) and are named according to their molecular 
masses. Extensively characterised Hsp representatives are Hsp70 with its co-
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chaperone Hsp40, Hsp90, Hsp60 also known as TRiC (TCP1 Ring Complex). In 
particular, Hsp70 and their co-chaperones Hsp40 are known to provide the motor 
power for protein translocation (Craig, 2018). 
 
1.4.1 The molecular chaperone class Hsp70 
One of the most ancient molecular chaperone classes is Hsp70 (Dekker et al., 
2015). The 70 kDa protein contains an N-terminal 45 kDa Nucleotide Binding 
Domain (NBD) and a 25 kDa C-terminal Substrate Binding Domain (SBD) (Mayer 
and Bukau, 2005; Mayer and Kityk, 2015). Through its NBD the chaperone binds 
and hydrolyses ATP leading to drastic conformational changes (Mayer and 
Bukau, 2005; Mayer and Kityk, 2015). The chaperone requires its co-chaperone, 
known as Hsp40, and a nucleotide exchange factor to complete the cycle and for 
returning to the ATP-bound-state (Mayer and Kityk, 2015) (reviewed in more 
detail in 1.4.2). With the help of the SBP, the chaperone recognises hydrophobic 
motifs in their client proteins, which only get exposed during protein synthesis, 
protein translocation or protein denaturation in case of stress (Craig, 2018; Mayer 
and Kityk, 2015). Every 30-40 amino acids proteins contain such hydrophobic 
Hsp70 recognition motifs (Rüdiger et al., 1997). Further, at the C-terminus an 
EEVD motif can be found, enabling the formation of multi-chaperone complexes 
(Blatch and Lässle, 1999; Freeman et al., 1995) and targeting proteins to their 
destinations (Craig, 2018). Due to their function in protein translocation, Hsp70 
proteins are interesting candidates to assist in protein translocation across PTEX 
(Koning-ward et al., 2009). In particular, their role in translocation processes to 
import proteins into the ER, chloroplast and mitochondria are well characterised 
and studied. In the ER, the chaperone BiP (Binding immunoglobulin Protein) 
helps proteins to pass the Sec61 translocon, to enter the ER after translation has 
been completed (Alder et al., 2005; Matlack et al., 1999). In the chloroplast, 
Hsp70 provides the driving force for importing proteins through translocons in the 
inner and outer chloroplast membrane (Shi and Theg, 2010). Finally, in the 
mitochondria, proteins are imported through TOM (Translocon Outer Membrane) 
and TIM (Translocon Inner Membrane) by using Hsp70 as “pulling” or motor force 
(Gambill et al., 1993). After passage Hsp70 can also assist in the refolding of 
cargo proteins (Horst et al., 1997).  
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There are 2 proposed models how Hsp70 assists in the translocation (Neupert 
and Brunner, 2002; Tomkiewicz et al., 2007): The power-stroke model suggests 
that Hsp70 actively pulls and unfolds the protein through the translocon via 
repeated ATP hydrolysis (Neupert and Brunner, 2002; Tomkiewicz et al., 2007). 
The other model called Brownian-rachet model relies, as the name indicates, on 
Brownian oscillations, which move the polypeptide chain forwards and backwards 
inside the translocon. Hsp70 binds tightly through ATP hydrolysis and stops the 
chain from moving backwards (Neupert and Brunner, 2002; Tomkiewicz et al., 
2007).  
 
Figure 5 The power-stroke and Brownian-rachet model (explained by taking the example of 
mitochondria) 
(a) Power-stroke model: The protein is actively pulled through the translocon by Hsp70. To this end, 
Hsp70 most probably uses the SBD as a lever arm. In its ATP-bound state, Hsp70 is recruited by Tim44 
(component of the translocon) and binds the emerging polypeptide chain. Due to the conformational 
change the polypeptide chain is pulled through the translocon. 
(b) Brownian-ratchet model: Based on the Brownian oscillation the polypeptide chain moves forwards and 
backwards inside the translocon. Hsp70, in its ADP-bound state, binds the polypeptide chain tightly and 
prevents it from sliding back. On the next forward move, the next Hsp70 binds and prevents the next 
piece from slipping back (modified from Neupert and Brunner, 2002). 
 
1.4.2 The co-chaperone Hsp40 
The Hsp70 protein family largely depend on their co-chaperones called Hsp40. 
The 40 kDa proteins are also referred to as J-proteins due the characteristic J-
domain (Hennessy et al., 2005; Kampinga and Craig, 2010). These J-proteins are 
mainly involved in identifying client proteins and recruiting Hsp70s. In humans 
~50 Hsp40 were identified (Kampinga and Craig, 2010). The Hsp40 display a big 
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variety in domains and can be divided into 3 classes according to their 
composition (Kampinga and Craig, 2010). This enormous Hsp40 diversity 
ensures Hsp70 specificity for many different proteins (Hennessy et al., 2005; 
Kampinga and Craig, 2010). Hsp40 and Hsp70 work in a complex cycle together 
with Nucleotide Exchange Factors (NEF) (Dekker et al., 2015). The co-chaperone 
Hsp40 first recognises and binds to client proteins by the J-domain. In the ATP-
bound or also called “open conformation”, the Hsp70 SBD is able to bind the 
substrate. Afterwards, Hsp40 increase the low intrinsic ATPase domain (NBD) of 
the Hsp70, causing a fast ATP hydrolysis and drastic conformational changes. In 
the ADP-bound state, the “lid” is closed and the Hsp70 tightly binds its client. 
With assistance of NEF the ADP is replaced with an ATP, resulting in the opening 
of the “lid”. The client protein is released and the cycle can start over again 
(Dekker et al., 2015). 
 
Figure 6 Overview of the Hsp70 cycle 
Hsp40 recognises the client protein and recruits Hsp70. In the ATP-bound (“open conformation”) Hsp70 can 
bind the client. The low intrinsic ATPase activity of Hsp70 is stimulated by Hsp40 and results in fast 
hydrolysis, leading to the ADP-bound state (“closed conformation”). Finally, NEF is needed to open the lid by 
exchanging the ADP to an ATP, releasing the client protein (Brehme and Voisine, 2016). 
 
Based on the aforementioned data, exported and parasite-encoded Hsp70 and 
Hsp40 would be the ideal candidates assisting in the protein translocation 
through the PTEX, and later refolding (Külzer et al., 2012, 2010). 
 
Introduction 
13 
1.4.3 Heat-shock proteins in P. falciparum  
P. falciparum encodes 92 chaperones and co-chaperones, thus, dedicating 2% of 
its genome to their expression (Acharya et al., 2007). The most abundantly 
expressed chaperone classes are Hsp70 and Hsp90 (Acharya et al., 2007), while 
the co-chaperone Hsp40 protein family amounts to 49 known proteins, making it 
the biggest co-chaperone group in P. falciparum (Botha et al., 2007). There are 6 
identified Hsp70s (PfHsp70-1, -2, -3, -z, -x and -y) in P. falciparum (Külzer et al., 
2012; Przyborski et al., 2015; Shonhai, 2010). Based on in silico analysis it is 
predicted that the chaperones fulfil their classical jobs, e.g. in the parasite’s 
mitochondria, PfHsp70-3 (Njunge et al., 2013) presumably forms a complex with 
Hsp90 and is involved in protein import (Przyborski et al., 2015; Young et al., 
2003). The parasite also expresses a homologue to the ER-chaperone BiP 
(Binding immunoglobulin Protein) (Kumar et al., 1991, 1988; Kumar and Zheng, 
1992). The plasmodial BiP is PfHsp70-2, which most likely assists in protein 
secretion as well as protein degradation (Przyborski et al., 2015). In 2012, Külzer 
and associates identified a parasite-encoded and exported Hsp70 chaperone 
called PfHsp70-x (in the following referred to as Hsp70x) (Külzer et al., 2012). 
Hsp70x is localised in the PV as well as in the host cytosol. In the cytosol, 
Hsp70x was revealed as a component of the so-called J-dots, which are mobile 
structures in the host erythrocyte containing also 2 PfHsp40 co-chaperones 
(PFA0660w and PFE0055c) (Külzer et al., 2012, 2010). First modelling and 
docking analysis pointed towards a functional PfHsp40-Hsp70x pairing (Hatherley 
et al., 2014) and later functional evidence for an interaction of PFA0660w and 
Hsp70x was obtained (Daniyan et al., 2016). Interestingly, the J-dots were 
associated with the major virulence factor EMP1 (Külzer et al., 2010). In 
consequence, it was hypothesised that Hsp70x might be involved in EMP1 
trafficking (Külzer et al., 2012). Additionally, due to its presence in the PV, 
Hsp70x might assist Hsp101 in the unfolding of cargo proteins (Elsworth et al., 
2016; Külzer et al., 2012; Seyffer et al., 2012; Zhang et al., 2017). This 
hypothesis was strongly supported by immunoprecipitation studies of the already 
introduced PTEX components PTEX150, EXP2 and Hsp101 (Elsworth et al., 
2016; Rhiel et al., 2016). In general, all these data made Hsp70x a promising 
candidate to play an essential role in protein transport to the host cell. Recently 
generated Hsp70x-deficient parasites did surprisingly not display a growth defect 
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(Charnaud et al., 2017). However, parasites depleted of Hsp70x presented 
reduced EMP1 export resulting in a diminished cytoadhesion (Charnaud et al., 
2017). In summary, Hsp70x is not essential, at least not in vitro, yet is closely 
linked to EMP1 transport (Charnaud et al., 2017).  
Another likely candidate assisting in protein translocation and refolding in the host 
cytosol is the host’s Hsp70 (Banumathy et al., 2002; Charpian and Przyborski, 
2008; Külzer et al., 2010). As already mentioned, the mature human erythrocyte 
contains several HsHsp. At least 4 different HsHsp70 and HsHsc70 (HSPA2, 
HSPA1L, HSPA1and HSPA8) were identified by mass spectrometry 
(D’Alessandro et al., 2010). Further, Hsp60, Hsp90 (HSP90AA1 and HSP90AB1) 
as well as BiP (HSPA5) can be found in the mature human erythrocyte 
(D’Alessandro et al., 2010).  
 
1.4.4  Is HsHsp70 exploited by P. falciparum? 
It is well established that bacteria and viruses often use components of the host 
cell e.g. Hsp70 for their own purposes (Agostini et al., 2000; Awe et al., 2008). 
The chaperones DnaK and DnaJ, E.coli Hsp70 and Hsp40, were first identified as 
pivotal components of λ phage (bacteria virus) replication (Konieczny and Zylicz, 
1999). There are also several indications that Plasmodium might exploit the 
host’s Hsp70. A study conducted in 1991 by Gromov and Celis found Hsp70 to 
be membrane-bound in P. knowlesi infected erythrocytes (Gromov and Celis, 
1991). Moreover, HsHsp70 and HsHsp90 were revealed to be recruited to the 
host membrane upon infection with P. falciparum (Banumathy et al., 2002). 
Interestingly, HsHsp70 was a member of a large complex with PfHRP1 (knob-
associated protein) at the RBC membrane (Banumathy et al. 2002). In 
consequence, it was speculated that HsHsp70 was probably associated with 
knob formation or the transport of knob components (Banumathy et al., 2002). 
Indeed, a very recent study analysing the knob proteome, presented HsHsp70 as 
a so far unknown component of the knobs (Alampalli et al., 2018). In addition, a 
number of studies investigated whether parasite-encoded and exported Hsp40 
might serve as co-chaperones of HsHsp70. Before it was known that the parasite 
itself exports Hsp70x, it was already speculated by Külzer et al. that the exported 
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PfHsp40 (PFE0055c or PFE55) interacts with HsHsp70 (Külzer et al., 2010). In 
2017, a proteomic analysis by Zhang and colleagues investigated the J-dot 
proteome and showed HsHsp70 to be present in a complex amongst PFE55 and 
Hsp70x (Zhang et al., 2017). Additionally, experimental data obtained by a yeast-
two hybrid screen identified exported Type II PfHsp40 as an interaction partner of 
HsHsp70 (Jha et al., 2017). Further evidence that a human chaperone acts as a 
motor force during the export of parasite proteins was obtained by pull-down 
assays of PTEX components (de Koning-Ward et al., 2009). These data can be 
supported by studies conducted by Dr. Stefan Charpian, which demonstrated that 
HsHsp70 is linked to the trans-side of the PVM (Charpian, 2008). In conclusion, it 
can be assumed that HsHsp70 is involved in assisting parasite-encoded proteins 
to pass the PTEX translocon and supporting experimental evidence was 
obtained. The translocation assay performed by Ansorge and colleagues already 
showed that a component in the host cell cytoplasm is needed for transport 
across the PVM (Ansorge et al., 1996). Remarkably, the addition of an excess 
amount of mutated Hsp70 to the host cell cytoplasm prevented the transport of 
the parasite-encoded protein GBP130 (Glycophorin-Binding Protein 130) 
(Günnewig, 2016). Taken together, all these data point towards a crucial role of 
HsHsp70 in the trafficking of parasite-encoded proteins. 
 
1.5 Aim of the study 
Based on the aforementioned data, the objective in this study was to investigate 
whether HsHsp70 has an essential role for the intra-erythrocytic development of 
the parasite. The mature human erythrocyte cannot be easily genetically 
modified, thus a new approach was needed to study the effect of HsHsp70 for 
parasite survival. In pharmacology, pre-loading also known as resealing, is used 
to allow the entrapment of small molecules into the mature erythrocyte 
(Bourgeaux et al., 2016; Magnani et al., 1998, 2002; Rossi et al., 2005). This 
method uses the pre-loaded erythrocytes as “carriers” for drugs, thereby avoiding 
degradation of the drug and ensuring biocompatibility if used erythrocytes 
originate from the identical patient in need of treatment (Bourgeaux et al., 2016; 
Magnani et al., 1998, 2002; Rossi et al., 2005). In this study, a resealing 
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approach was implemented and erythrocytes were pre-loaded with an excess 
amount of a mutated HsHsp70 to achieve a classical dominant negative effect. 
To this end, the inactive HsHsp70K71M mutant was chosen. The K71M mutation, 
within the NBD of the chaperone, disrupts the chaperone’s ability to hydrolyse 
bound ATP and renders it inactive (O’Brien et al., 1996). After establishing the 
resealing method, the resealed red blood cells (rRBC) pre-loaded with 
HsHsp70K71M were infected with P. falciparum parasites. Further controls, e.g. 
rRBC pre-loaded with no protein and rRBC pre-loaded with a functional 
HsHsp70wt, were used to compare growth rates in the presence of the 
HsHsp70K71M mutant. The growth was analysed by lactate dehydrogenase 
assays and flow cytometry. Additionally, the localisation of HsHsp70 in the non-
infected as well as in the infected erythrocytes was studied. Therefore, resealing 
assays with a fluorescently labelled HsHps70wt were carried out. First, the 
localisation was determined in non-infected erythrocytes before these 
fluorescently labelled HsHsp70wt rRBC were infected with P. falciparum. 
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2 Material and methods 
2.1 Materials 
2.1.1 Disposable consumables 
If not stated differently all used disposable plastic ware, e.g. pipette tips, 
serological pipettes and falcons, was purchased from: Sarstedt (Hamburg), 
Greiner Bio-one (Frickenhausen), VWR (Darmstadt), Miltenyi Biotec (Bergisch 
Gladbach), Roth (Karlsruhe) or Eppendorf (Hamburg). 
 
2.1.2 Chemicals  
If not stated differently all used chemicals were purchased from: Sigma Aldrich 
(Taufkirchen), Peqlab (Erlangen), Roth (Karlsruhe), Applichem (Darmstadt), 
ThermoFisher (Dreieich) or Merck (Darmstadt). 
 
2.1.3 Dyes 
Table 1 List of used dyes with corresponding manufacturer 
Name Purpose and used 
concentration/dilution 
Company 
Cy2 succinimidyl ester Labelling of HsHsp70: 0.3 mg 
dye/2.8 mg protein 
ThermoFisher 
(Dreieich) 
DAPI IFA, flow cytometry: 1 µg/mL Sigma (Taufkirchen) 
Oregon green carboxylic-
acid, succinimidyl ester 
Labelling of HsHsp70: 0.3 mg 
dye/2.8 mg protein 
ThermoFisher 
(Dreieich) 
Rhodamine B-
isothiocyanate-Dextran 
Resealing: 40 mg/mL Sigma (Taufkirchen) 
SYBR green Flow cytometry: 1:2000 Sigma (Taufkirchen) 
 
2.1.4 Equipment  
Table 2 List of used equipment with corresponding manufacturer 
Equipment Company 
Centrifuge 5415R Eppendorf (Hamburg) 
Centrifuge 5417C Eppendorf (Hamburg) 
Centrifuge 5417D Eppendorf (Hamburg) 
Centrifuge Labofuge 400e Heraeus (Hanau) 
Centrifuge Mikro 220R Hettich (Tuttlingen) 
Centrifuge Universal 320 Hettich (Tuttlingen) 
Material and methods 
18 
Citation 3 Imaging Reader BioTek, (Bad Friedrichshall) 
CO2 Inkubator C200 Labotec (Göttingen) 
FACS Canto BD (Franklin Lakes, USA) 
Heatblock DB1010 Alpha Labs (Hampshire) 
HERAsafe HS 12  Heraeus (Hanau) 
Light microscope Aixostar plus Carl Zeiss (Göttingen) 
Light microscope Primo Star Carl Zeiss (Göttingen) 
Lumat LB9507 luminometer  Berthold Technologies (Bad Wildbad) 
Magnetic stirrer IKA (Staufen) 
pH-Meter GPRT 1400N Greisinger Electronic GmbH (Regenslauf) 
Power supply EPS 301 Amersham pharmacia biotech (Amersham, 
GB) 
Precision balance portable Sartorius (Göttingen) 
Rolling Mixer TRM50 MAGV (Rabenau) 
Semi-Dry Blotter IDL (Nidderau) 
Thermomixer 5436 Eppendorf (Hamburg) 
Typhoon FLA 7000 Amersham GE Healthcare (Chalfont St Giles, 
GB) 
VarioMACS  Milteny Biotec (Bergisch-Gladbach) 
Waterbath Köttermann Köttermann (Uetze) 
Waterbath U3 Julabo (Seelbach) 
 
2.1.5 Cell culture media  
Table 3 Composition of used cell culture media 
Media type Composition 
Adherent cells  
 
DMEM complete 
 
 
 
 
 
DMEM incomplete 
 
 
DMEM 500 mL (Gibco, Karlsruhe) 
10% FCS (CC Pro, Oberdorla) 
0.5 mg Streptomycin (CC Pro, 
Oberdorla) 
100 U Penicillin (CC Pro, Oberdorla) 
 
DMEM 500 mL (Gibco, Karlsruhe) 
0.5 mg Streptomycin (CC Pro, 
Oberdorla) 
100 U Penicillin (CC Pro, Oberdorla) 
Plasmodium falciparum 
 
RPMI  
 
 
 
 
 
RPMI-Albumax 
 
 
RPMI 1640 500 mL (Gibco, Karlsruhe) 
10% Human Plasma 0+ 
50 mg Neomycin (Sigma, Taufkirchen) 
0.2 mM Hypoxanthine (CC Pro, 
Oberdorla) 
 
RPMI 1640 500 mL (Gibco, Karlsruhe) 
5% Human Plasma 0+ 
5% AlbuMAX II (Gibco, Karlsruhe) in 
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RPMI 1640 
50 mg Neomycin (Sigma, Taufkirchen) 
0.2 mM Hypoxanthine (CC Pro, 
Oberdorla) 
 
2.1.6 Bacteria media 
Table 4 Composition of used bacteria media 
Media Ingredients 
Luria-Bertani (LB) Agar 35 g/L LB agar 
SOB medium 20 g/L Peptone 
5 g/L Yeast extract 
10 mM NaCl 
2.5 mM KCl 
20 mM MgCl2 
SOC medium SOB medium 
20 mM C6H12O6 
Super broth medium 35 g/L Tryptone 
20 g/L Yeast extract 
5 g/L NaCl 
 
2.1.7 Cell culture reagents  
Table 5 List of used cell culture reagents with corresponding manufacturer 
Reagent Company 
Human plasma and erythrocytes, blood 
group 0, Rhesus factor + 
Blood donation centre, Mannheim 
Lipofectamine RNAiMAX ThermoFisher (Dreieich) 
Opti-MEM ThermoFisher (Dreieich) 
siRNA 
HSPA1A pre-designed siRNA (s6965) 
Silencer Select, Negative siRNA 
(AS029YZ6) 
 
Ambion ThermoFisher (Dreieich) 
Ambion ThermoFisher (Dreieich) 
WR99210 Jacobus Pharamaceuticals, (Princeton, 
USA) 
 
2.1.8 Cell lineages 
Table 6 List of used cell lineages 
Strain  Description Origin 
Human 
 
HuH7  
 
 
Immortalized hepatocellular 
carcinoma cell line 
(Nakabayashi et al., 1982) 
 
 
 
Kind gift from AG Müller, 
Parasitology, Heidelberg 
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Parasite  
 
P. falciparum 
3D7 wildtype 
 
 
3D7-∆PfHsp70x  
 
 
 
3D7-HsHsp70-
mCherry 
 
 
P. berghei 
ANKA-red-green 
line 
 
 
 
Wildtype, Clone of NF54 
(Walliker et al., 1987) 
 
Parasites deficient of 
PfHsp70x 
 
 
Parasites express a 
STEVOR 1-80-mCherry-
HsHsp70 fusion protein 
 
 
Parasites express mCherry 
under the CS promoter, 
while GFP is expressed 
under the ef1α promoter 
 
 
 
AG Przyborski, Parasitology 
 
 
Kind gift from Brendan 
Crabb, Burnet Institute, 
Australia 
 
Produced during the thesis 
(construct: AG Przyborski, 
Parasitology) 
 
 
Kind gift from AG 
Frischknecht, Parasitology 
 
 
Bacteria 
 
E. coli BL21-Rosetta 
(DE3) 
 
 
Expression strain 
 
 
Kind gift from AG Mayer, 
ZMBH, Heidelberg 
 
2.1.9 Protein size marker 
 
Figure 7 PageRuler Prestained protein ladder (ThermoFisher) 
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2.1.10 Vector maps 
 
Figure 8 Expression vectors for HsHsp70
wt
 and HsHsp70
K71M 
(A) pSUMO-HsHsp70
wt
 
(B) pSUMO-HsHsp70
K71M
 
Both vectors were a kind gift from AG Mayer, ZMBH, Heidelberg and express a 6xHis-tag fused to SUMO-
tag and HsHsp70
wt
 or HsHsp70
K71M
. 
 
2.1.11 Antibodies 
Table 7 List of primary antibodies 
Name Origin Dilution Manufaturer 
α-Aldolase Rabbit WB: 1:5000 AG Przyborski 
α-DnaK  Mouse WB: 1:2000 Abcam (Cambridge, 
UK) 
α-GAPDH Mouse WB: 1:500 Sigma (Taufkirchen) 
α-Glycophorin 
A&B 
Mouse WB: 1:1000 AG Przyborski 
α-HsHsc70 Mouse  WB: 1:1000 StressMarq 
(Victoria, British 
Columbia) 
α-HsHsp70 Mouse WB: 1:500 Santa Cruz 
(Heidelberg) 
α-Ovalbumin Rabbit WB:1:500 AG Przyborski 
α-PfHsp70x Rabbit WB: 1:500 
IFA: 1:500 
AG Przyborski 
α-PfSBP1 Rabbit WB: 1:1000 
IFA: 1:500 
AG Przyborski 
α-RFP Mouse IFA: 1:500 Rockland (Limerick, 
USA) 
 
Table 8 List of secondary antibodies 
Name  Western 
blot 
IFA 
Origin Dilution Company 
α-mouse-Cy2 IFA Goat 1:2000 Jackson (West 
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Grove, USA) 
α-mouse-Cy3 IFA Goat 1:2000 Jackson (West 
Grove, USA) 
α-mouse-HRP WB Goat 1:2000 Dako (Glostrup, 
Denmark) 
α-rabbit-Cy2 IFA Goat 1:2000 Jackson (West 
Grove, USA) 
α-rabbit-Cy3 IFA Goat 1:2000 Jackson (West 
Grove, USA) 
α-rabbit-HRP WB Goat 1:2000 Dako (Glostrup, 
Denmark) 
 
2.1.12 Buffers  
Table 9 Compostion of buffers 
Buffer Ingredients 
Ammonium peroxidsulfate (APS) 10% APS in ddH2O 
ATP 100 mM ATP pH 7 (NaOH) in ddH2O 
Blocking solution IFA 3% Bovine serum albumin in PBS (1x) 
Blocking solution WB 5% milk powder in PBS (1x) 
Blotting buffer (1x) 48 mM Tris HCl pH 9.5 
39 mM Glycine 
0.04% SDS 
20% MeOH (add fresh) 
in ddH2O 
Coomassie Blue staining solution 25% MeOH 
10% Acetic acid 
0.1% Coomassie Brilliant Blue 
in ddH2O 
Coomassie destain  25% MeOH 
10% Acetic acid 
in ddH2O 
Cytomix stock solutions Stock solution I 
10 M KOH in ddH2O 
 
Stock solution II 
250 mM HEPES 
20 mM EGTA pH 7.6 
with stock solution I 
 
Stock solution III 
1 M Phosphate Buffer pH 7.6 in ddH2O 
 
Cytomix (100 mL) 
120 mM KCl  
150 µM CaCl2  
1 mL Stock solution III 
10 mL Stock solution II 
5 mM 1 M MgCl2 
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D-Sorbitol 5% D-Sorbitol  
autoclaved before use in S2 
ECL 250 mM Luminol in DMSO 
90 mM P. commaric acid in DMSO 
1 M Tris HCl pH 8.5 
in ddH2O 
Fixation solution 4% PFA 
0.0075 % Glutaldehyde 
in PBS (1x) 
Freezing solution 28% Glycerol 
3% D-Sorbitol 
0.65% NaCl 
in ddH2O, autoclaved before use in S2 
LDH buffer 100 mM Tris HCl pH 8 
50 mM Sodium-Lactate 
0.25%Triton-X-100 
in ddH2O 
Luciferase Refolding Assay Refolding Buffer 
25 mM HEPES KOH pH 7.6 
100 mM KOAc 
10 mM Mg(OAc)2 
2 mM ATP pH 7 
5 mM DTT 
in ddH2O 
 
Assay Buffer 
100 mM Phosphate Buffer pH 7.6 
25 mM Glycly-glycine pH 7.4 
100 mM KOAc 
15 mM Mg(OAc)2 
5 mM ATP pH7 
in ddH2O 
PBS (10x) 1.4 M NaCl 
28 mM KCl 
83 mM K2HPO4 
19 mM KH2PO4 
pH 7.4, in ddH2O 
Ponceau  0.2% Ponceau S 
3% Trichloroacetic acid 
in ddH2O 
Protein purification buffers Lysis buffer 
20 mM Tris HCl pH 7.9 
100 mM KCl 
1 mM PMSF (added before lysis) 
1 mM Pepstatin (added before lysis) 
1 mM Leupetin (added before lysis) 
1 mM Aprotitin (added before lysis) 
in ddH2O 
 
Buffer A1 
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20 mM Tris HCl pH 7.9 
100 mM KCl 
in ddH2O 
 
Buffer A2 
20 mM Tris HCl pH 7.9 
1 M KCl 
in ddH2O 
 
Buffer B 
20 mM Tris HCl pH 7.9  
100 mM KCl 
250 mM Imidazol 
in ddH2O 
 
ATP Buffer 
40 mM Tris HCl pH 7.9 
100 mM KCl 
5 mM MgCl 
5 mM ATP 
in ddH2O 
 
Buffer C 
40 mM HEPES KOH pH 7.6 
10 mM KCl 
5 mM MgCl2 
in ddH2O 
 
Buffer D 
40 mM HEPES KOH pH 7.6 
10 mM KCl 
5 mM MgCl2 
10 mM beta-mercaptoehtanol 
5% Glycerol 
in ddH2O 
 
Buffer E 
40 mM HEPES KOH pH 7.6 
1 M KCl 
5 mM MgCl 
5% Glycerol  
in ddH2O 
 
Buffer F 
40 mM HEPES KOH pH 7.6 
50 mM KCl 
5 mM MgCl2 
10 mM beta-mercaptoethanol 
10% Glycerol  
in ddH2O 
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Quencing solution 125 mM Glycine 
1% Triton X 
in PBS (1x) 
RIPA buffer 50 mM Tris HCl pH 7.5 
1% Triton-X 
0.1% SDS 
5 mM EDTA 
150 mM NaCl 
50 mM NaF 
0.5% NaDOC 
in ddH2O 
SDS running buffer (5x) 124 mM Tris 
960 mM Glycin 
0.05% SDS 
in ddH2O 
SDS-loading dye (2x) 100 mM Tris HCl pH 6.8 
5 mM EDTA  
20% Glycerol 
4% SDS 
0.2% Bromophenol blue 
100 mM DTT 
in ddH2O 
Separating buffer (Tris-HCl pH 8.8) 1.5 M Tris HCl pH 8.8 
0.4% SDS 
in ddH2O 
Stacking buffer (Tris-HCl pH 6.8) 500 mM Tris HCl pH 6.8 
0.4% SDS 
in ddH2O 
Thawing solutions  Solution I 
12% NaCl in ddH2O 
 
Solution II 
1.6% NaCl in ddH2O 
 
Solution III 
0.9% NaCl 
0.2% C6H12O6  
in ddH2O 
WR 99210 20 mM WR99210 in DMSO 
Final concentration:2.5 nM 
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2.2 Methods 
2.2.1 Cell culture techniques for human adherent cells: HuH7 
2.2.1.1 In vitro culturing of human adherent cells 
Cell culturing of human adherent cells (HuH7, liver carcinoma cells) was 
performed under sterile conditions and cells were maintained at 60-80% 
confluency. The standard culture medium DMEM was supplemented with 10% 
FCS, 100 U penicillin and 0.5 mg streptomycin. Cultures were kept at 37°C and 
5% CO2. 
 
2.2.1.2 Splitting and counting of adherent cells 
Every 2-3 days cells were splitted for continuous culturing or the desired number 
of cells was inoculated for experiments such as transfection. A confluent culture 
was first washed using DMEM media without any supplements. Afterwards, 6 mL 
trypsin/EDTA (1x) per T75-flask was added to detach cells from the culture flask. 
The trypsin/EDTA was incubated for 3 min at 37°C. Next, cell detachment was 
confirmed using an inverted microscope. To inactivate the trypsin/EDTA an equal 
amount of standard culture media (including FCS) was added. Subsequently, 
cells were centrifuged at 800xg for 2 min. The pellet was resuspended in the 
desired volume of standard cell media for splitting and transferred to a fresh flask 
with 12 mL standard medium per T75-flask. For counting, the pellet was 
resuspended in 10 mL culture medium (for T75-flask). The completely 
resuspended cells were mixed in a 1:1 ratio with trypan blue (0.04% in PBS) and 
10 µL were applied to a Neubauer counting chamber. Cells present in 4 big 
squares were counted and the total cell number was calculated using the formula 
shown below.  
Cell number/mL =
𝑐𝑜𝑢𝑛𝑡𝑒𝑑 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 4 𝑠𝑞𝑢𝑎𝑟𝑒𝑠
4
∗ 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 ∗ 104 
 
 
Table 10 contains numbers of seeded cells for the different culture flasks. 
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Table 10 Cell numbers seeded for different culture flasks 
 24 well plate 96 well plate 
Cm2 1 0.2 
Cell number 30,000 cells 10,000 cells 
 
2.2.1.3 Thawing of human adherent cells 
After 15 passages the cells usually started to grow slower and transfection 
efficiencies were reduced. To avoid such behaviour cultures were replaced with a 
freshly thawed aliquot after 15 passages. To this end, cells were allowed to thaw 
at 37°C and were subsequently transferred to a falcon containing 10 mL pre-
warmed DMEM standard medium. Then, cells were centrifuged at 800xg for 2 
min and washed once in standard media. Finally, a fresh culture flask was 
inoculated with the cells and grown at 37°C with 5% CO2. 
 
2.2.1.4 Freezing of human adherent cells 
To preserve cells, a confluent flask was trypsinised as explained in 2.2.1.2. 
Afterwards, the pellet was resuspended in 200 µL 20% DMSO in DMEM, 200 µL 
50% FCS in DMEM and cells were stored at -80°C.  
 
2.2.1.5 siRNA transfection  
A siRNA downregulation of HsHsp70 in HuH7, a liver carcinoma cell line, was 
used to investigate the role of HsHsp70 in parasite survival. The Lipofectamine 
RNAiMAX tranfection kit from ThermoFisher Scientific was used for this purpose. 
Transfection was conducted as described in the instruction manual with some 
slight variations explained in the following. Two pre-designed siRNAs, one 
directed against HsHsp70 (HSPA1A) and one scrambled RNA (scraRNA), were 
ordered from ThermoFisher Scientific. A reverse transfection, which means first 
DNA was added and afterwards the cells were added on top, was performed to 
introduce the siRNA into the cells. The following Table 11 shows a typical 
transfection in 96 and 24 well plates (volume/well).  
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Table 11 Transfection of HuH7 cells in 96 and 24 well plates 
  96 well plate 24 well plate 
Tube A OptiMem media 
Lipofectamine 
RNAiMAX 
10 µL 
0.6 µL 
50 µL 
3 µL 
Tube B OptiMem media 
siRNA (10 µM) 
10 µL 
0.2 µL 
50 µL 
1 µL 
 
After preparation of mastermixes, tube A and B were mixed and incubated at RT 
for 20 min. In the meantime, the cells were trypsinised and counted. Then, the 
lipofectamine siRNA mix was pipetted into each well (10 µL/96 well plate and 50 
µL/24 well). Subsequently, the HuH7 cells, diluted in media without Pen/Strep, 
were evenly distributed on the plate. For a 24 well plate 30,000 and for a 96 well 
plate 10,000 cells/well were used. After 12-18 h the medium was replaced with 
DMEM complete containing Pen/Strep. Two days post-transfection Plasmodium 
berghei sporozoites (numbers and dissection explained in 2.2.1.6) were added 
and the western blot samples were taken to check the downregulation.  
 
2.2.1.6 Dissection of Anopheles mosquitoes 
In order to study the role of HsHsp70 on liver stage development of P. berghei, 
red-green sporozoites were used to infect the HsHsp70 downregulated HuH7 
cells. The parasites express mCherry under the CS promoter, while GFP is 
expressed under control of the e1fα promoter (kind gift from AG Frischknecht). 
First, mice were infected with the help of frozen parasite stabilates. Due to the 
lack of a FELASA certificate for the author, infection experiments were performed 
by Jessica Kehrer (AG Frischknecht, Parasitologie). Once mice were infected 
and showed exflagellating gametocytes, mosquitoes were allowed to take a blood 
meal from the infected mice. The infection of the mosquitoes and all dissections 
were executed under S3 conditions. 17 days post-infection, the salivary glands 
were dissected to obtain sporozoites. With the help of a bottle of warm H2O 
female mosquitoes were attracted to one side of the cage and were sucked in a 
tube using a small pump. Afterwards, mosquitoes were carefully transferred to a 
falcon and placed on ice for several minutes for immobilisation. The narcotised 
mosquitoes were placed on a slide with one drop of PBS and examined under a 
binocular microscope. Using 2 cannulas of different sizes the 6 legs of the 
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mosquito were removed. Afterwards, the bigger cannula was used to carefully 
secure the thorax of the mosquito, applying not too much pressure to avoid 
injuries of the thorax, which would contaminate the salivary glands dissection. 
The smaller cannula was used to apply pressure on the head, which was pulled 
slowly to the side. Salivary glands appeared shiny under the microscope and the 
head was in the final step removed from the glands. Depending on the infection 
rate, up to 100 mosquitoes were dissected to gain 500,000 sporozoites. After 
dissection, salivary glands were transferred to an Eppendorf tube and smashed 
with the help of a small plastic pestle to release sporozoites from the glands. The 
mixture was then applied to a cell strainer (0.2 µm) to separate the glands from 
the sporozoites and was centrifuged at 2,100xg for 2 min. Next, the supernatant 
was smashed and centrifuged again. The number of sporozoites per mL was 
determined using a Neubauer chamber. The dissection was performed with the 
help of Marta Marchado (AG Ganter, Parasitology). Finally, sporozoites were 
diluted to the desired number in DMEM complete medium and were allowed to 
infect HuH7 cells for 2 h. For a 24 well plate with 30,000 Huh7 cells, 40,000 
sporozoites were added and for a 96 well plate with 10,000 HuH7 cells, 10,000 
sporozoites were added. In the end, the media was changed every day and liver 
stages were analysed 48 h post-infection by flow cytometry. 
 
2.2.2 Cell culture techniques for Plasmodium falciparum 
2.2.2.1 In vitro culturing of Plasmodium falciparum  
Cell culturing was performed under a lamina flow and cultures were cultivated in 
4% haematocrit with RPMI 1640 medium supplemented with 10% human 0+ 
plasma, 50 mg neomycin and 0.2 mM hypoxanthine (Trager and Jensen, 1976). 
All parasite cultures were maintained at 5% CO2, 5% O2 at 37°C in an incubator. 
 
2.2.2.2 Giemsa staining of blood smears 
Blood smears were prepared and stained using giemsa staining solution to 
monitor the parasitemia of the cultures. Therefore, a 5 µL sample of a culture was 
taken and a thin smear was prepared on a slide. Afterwards, the smear was fixed 
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for several seconds in 100% methanol. Thereafter, the slide was air dried and 
placed in giemsa staining solution (1:5 dilution in H2O) for 10 min. The slide was 
rinsed with water and air-dried. Finally, the slide was analysed under the light 
microscope at 63x objective magnification with oil immersion.  
 
2.2.2.3 Freezing of P. falciparum  
In order to conserve parasite lines, a culture with high parasitemia around 10%, 
containing mainly ring stages, was centrifuged for 3 min at 2,100xg. The pellet 
was resuspended in the equal pellet volume of freezing solution and aliquoted 
(~500 µL/cryotube) to cryotubes. Subsequently, parasites were frozen in liquid 
nitrogen and stored at -80°C. 
 
2.2.2.4 Thawing of P. falciparum 
Stocks of parasite lines were thawed at 37°C, before slowly and gently mixing the 
freshly thawed parasites with 250 µL of pre-warmed 12 % sterile NaCl. After a 2 
min rest, parasites were transferred to a 15 mL falcon and 5 mL pre-warmed 
1.6% sterile NaCl was added dropwise. Followed by another 2 min rest, 5 mL of 
0.2% glucose/0.9% NaCl was added dropwise. Afterwards, the parasites were 
centrifuged at 2,100xg, the supernatant was removed and parasites were washed 
in 10 mL culture media. Finally, the parasite pellet was filled up with fresh 0+ 
blood (up to 500 µL) and 12 mL culture medium was added. Depending on the 
parasite line the appropriate antibiotic was added and parasites were maintained 
at 5% CO2 and 5% O2 at 37°C.  
 
2.2.2.5 Synchronisation of P. falciparum in vitro culture by sorbitol 
A synchronous P. falciparum culture is obtained by applying a sorbitol treatment, 
since trophozoites and schizonts are ruptured by sorbitol (Lambros and 
Vanderberg, 1979). Therefore, a mixed culture was transferred to a 15 mL falcon 
and centrifuged for 2 min at 2,100xg. Afterwards, the pellet was resuspended in 
the 10 times pellet volume with 5% sterile sorbitol. After an incubation of 10 min 
at 37°C, the parasites were centrifuged at 2,100xg for 2 min and washed in 10 
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mL culture medium. Finally, the pellet was resuspended in 12 mL culture 
medium. 
 
2.2.2.6 Enrichment of P. falciparum trophozoites 
In vitro P. falciparum cultures cannot reach a parasitemia above 10%. Therefore, 
some experiments require an enrichment to reach higher parasitemia. There are 
2 methods to enrich parasites, a gelafundin treatment or Magnetic Activated Cell 
Sorting (MACS). In the following both techniques are explained in detail. 
 
2.2.2.7 Trophozoite enrichment by gelafundin 
Non-infected erythrocytes can be separated from infected ones using gelafundin 
(Pasvol et al., 1978). The infected erythrocytes contain so-called knobs that were 
introduced to the host cell shortly after infection with Plasmodium. If a culture is 
mixed with gelafundin non-infected erythrocytes sink to the bottom of the tube, 
while the infected erythrocytes stay longer in the supernatant. In consequence, 
the gelafundin treatment achieves 2 goals. First, it enriches the parasites and 
secondly, it helps to ensure that the in vitro culture still contains “knobby” 
parasites, as parasites tend to loose these knob structures under culture 
conditions (Langreth et al., 1979). Usually, a culture high in trophozoites was 
pelleted at 2,100xg for 2 min. Afterwards, the pellet was resuspended in the 10 
times pellet volume with a 2.5% gelafundin solution (diluted in RPMI without any 
supplements). The falcon was incubated for 12-15 min in vertical position at 
37°C. Finally, the supernatant was transferred to a fresh falcon, washed 2 times 
in culture medium and the parasitemia was determined via giemsa smears. In the 
end, a fresh plate with media and blood was inoculated with the desired 
parasitemia. 
 
2.2.2.8 Magnetic Activated Cell Sorting (MACS) of P. falciparum 
Magnetic activated cell sorting (MACS) allows the efficient enrichment of 
parasites, often leading to a 99% parasitemia. It exploits the formation of 
magnetic hemozoin crystals by the parasite as a result of its usage of 
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haemoglobin as a nutritional source, and its heme detoxification pathway (Kim et 
al., 2010). Therefore, only infected cells are held back to the column, which is 
attached to a big magnet and finally parasites can be eluted by removing the 
column from the magnetic field. All parasite enrichments using MACS were 
performed with 10% trophozoite cultures. The MACS column was equilibrated 
with 4 column volumes of pre-warmed PBS, followed by 4 column volumes of 
pre-warmed 3% BSA in RPMI during which the drop rate was set to 1 drop/s. 
Then, the parasites were applied to the column and the flow through was 
collected. After the first passage, the collected flow through was added a second 
time. Next, the column was washed with 3% BSA in RPMI until the flow through 
was not reddish any longer. Finally, the parasites were eluted by removing the 
column from the magnetic field and adding culture media. The eluate was 
centrifuged at 2,100xg for 2 min. The parasitemia was checked by giemsa 
smears. 
 
2.2.2.9 Transfection of P. falciparum  
Transfections were performed by electroporation, a technique that applies an 
electrical field to the parasite to increase membrane permeability and thereby 
allows the introduction of foreign DNA into the cell (Waters et al., 1997). Plasmid 
DNA was isolated and precipitated according to the QIAGEN Maxi Prep Kit 
instructions. A highly synchronous P. falciparum culture with a parasitemia of 5% 
and mainly ring stages was used for transfection. First, 500 µL (~100 µg) plasmid 
DNA was precipitated with the double volume of ice cold 100% ethanol and 10% 
5 M sodium acetate (pH 5.2). The sample was centrifuged for 15 min at 36,000xg 
at 4°C. The supernatant was removed carefully and the pellet was washed in 500 
µL 75% ice cold ethanol in ddH2O. The supernatant was removed under sterile 
conditions and the pellet was carefully air-dried. Next, 30 µL TE buffer (pre-
warmed to 50°C) was added to the pellet and the pellet was allowed to dissolve 
for 10 min at 50°C with shaking. In the meantime, a falcon with 12 mL albumax 
medium and 400 µL freshly obtained 0+ blood (haematocrit 100%) was prepared 
and pre-warmed at 37°C. Next, a 400 µL aliquot of cytomix was pre-warmed at 
37°C. After the pellet had completely dissolved, 370 µL of cytomix was added 
and well mixed with the DNA. Then, 200 µL of infected erythrocytes were added 
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and mixed well. The mixture was transferred to a 0.2 cm electroporation cuvette 
and electroporation was conducted at a voltage of 0.310 kV and a capacity of 950 
µF, resulting in a time constant between 10-13 ms. Subsequently, the transfected 
cells were carefully transferred to the prepared falcon with Albumax medium and 
0+ blood. The cuvette was washed several times with the Albumax/blood mixture. 
The transfected culture was placed in a small culture dish and allowed to rest for 
the next 4-6 h. Finally, the culture was supplied with the appropriate selective 
agent. The used medium was exchanged daily with fresh medium and 20 µL of 
fresh human 0+ erythrocytes were added until all parasites were killed. 
Afterwards, twice a week the culture was monitored for growth by giemsa smears 
and fresh medium, 20 µL fresh human 0+ erythrocytes, the respective selective 
agent was added. Once parasites were detected and parasitemia reached 2% 
the culture was spilt and transfected strains were cryopreserved.  
 
2.2.3 Methods of protein biochemistry  
2.2.3.1 Transformation of E. coli  
Foreign DNA is introduced into Escherichia coli (E. coli) in a process called 
transformation. The electrocompetent cells were slowly thawed on ice and 1 µL of 
plasmid DNA was added to 50 µL of cells. Then, the mixture was pipetted into a 
0.2 cm electroporation cuvette and electroporation was performed at 2.5 kV, 25 
µF and 200Ω. Subsequently, the cells were mixed with 1 mL SOC-medium and 
grown for 1 h at 37°C. Finally, bacteria were plated on LB agar with the required 
antibiotics and incubated at 37°C overnight.  
 
2.2.3.2 Protein expression 
The plasmids for recombinant protein expression and purification of HsHsp70wt 
and HsHsp70K71M were a kind gift from Prof. Mayer, ZMBH Heidelberg, and 
protein purification was performed in collaboration with the Mayer lab at the 
ZMBH. First, plasmids were introduced into E. coli Rosetta (DE 3) competent 
cells (provided from the research group Mayer) and plated on LB plates 
containing kanamycin (50 µg/mL) and chloramphenicol (50 µg/mL). On the next 
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day, 100 mL fresh SB medium with kanamycin (50 µg/mL) and chloramphenicol 
(50 µg/mL) were inoculated with a colony and grown overnight at 37°C with 200 
rpm agitation. Then, 8 L of fresh SB medium with kanamycin (50 µg/mL) and 
chloramphenicol (50 µg/mL) were inoculated to an OD600 of 0.05-0.1 with the 
overnight culture. The bacteria were grown at 37°C with 200 rpm agitation until 
an OD600 of 0.8 was obtained. Preceding induction, a small sample was taken as 
a non-induced control of protein expression. Protein expression was induced by 
addition of 1 mM IPTG and 0.3 M NaCl. Afterwards, cells were incubated 
overnight at 20°C with agitation at 200 rpm. The bacteria were harvested at 
3,000xg for 20 min at 4°C. Finally, the bacterial pellet was frozen at -80°C. The 
success of protein expression was checked via SDS-PAGE and Coomassie 
staining. 
 
2.2.3.3 Protein purification 
The 2 proteins were expressed as N-terminal 6-His-SUMO-tagged proteins to 
obtain pure untagged HsHsp70wt and HsHsp70K71M. To this end, both proteins 
were affinity-purified using Ni-NTA (nickel charged affinity resin) beads. The 
elution is performed by adding imidazole and the His-SUMO-tag is cleaved off by 
usage of the Ulp1-protease. Afterwards, Ni-NTA beads will retain the His-SUMO-
tag in the column, while the tagless protein can be eluted. Finally, depending on 
the protein purity, the protein can be further purified by ion-exchange 
chromatography (Figure 9). 
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Figure 9 Schema of His-SUMO-tagged protein purification of HsHsp70
wt
 and HsHsp70
K71M
 
HsHsp70
wt
 and HsHsp70
K71M
 can be affinity-purified using Ni-NTA beads due to the N-terminal His-SUMO-
tag. The elution is performed with imidazole. Afterwards, the N-terminal His-SUMO-tag is removed by 
cleavage with the Ulp1-protease and incubation with Ni-NTA beads. The purified protein can be found in the 
eluate. If needed protein purity can be increased by ion exchange chromatography.  
 
All purification steps were performed on ice at 4°C to avoid protein degradation. 
The pellets were thawed on ice and 100 mL pre-cooled lysis buffer (with 1 mM 
pepstatin, 1 mM leupeptin and 1 mM aprototin) were added per 2 L of starting 
culture. Afterwards, the cells were lysed using a microfluidizer and centrifuged for 
20 min at 20,000xg at 4°C. Then, the supernatant was centrifuged again for 2 h 
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at 100,000xg at 4°C. Afterwards, the supernatant was mixed with 5 mL Ni-NTA 
beads that were equilibrated against buffer A1 and incubated for 15 min at 4°C at 
end-over-end rotation. The mixture was transferred into a column. The column 
was first washed with 20 Column Volumes (CV) of buffer A1, afterwards with 20 
CV of A2, then, with 2 CV of A1 again. Subsequently, 10 CV of ATP-buffer were 
added and after 2 CV had passed, a stop cock was applied to stop the flow. The 
ATP-buffer was incubated for 30 min at 4°C. After the wash with the ATP-buffer, 
the protein was eluted with double CV of buffer B. The purification was checked 
by SDS-PAGE and Coomassie staining. To cleave the His-tag off the protein, the 
eluates were pooled and the SUMO-protease Ulp1 was added during overnight 
dialysis against buffer C. On the next day, 1 mL Ni-NTA beads in buffer C was 
added and incubated for 15 min at 4°C at end-over-end rotation. Then, the 
mixture was applied to the column, the flow-through contained the pure-untagged 
HsHsp70wt or HsHspK71M. If required, the purity of the protein was further 
increased by ion exchange chromatography, using a Resource Q column (GE 
Healthcare). The column was equilibrated with buffer D and elution was achieved 
with a KCl gradient from 0-100% of buffer E. The flow rate was set to 1 mL/min 
and a fraction size of 0.5 mL was collected. Finally, fractions were screened for 
protein purity via SDS-PAGE followed by Coomassie staining. Protein fractions 
with high purity were pooled and dialysed against buffer F overnight. Protein 
concentration was determined and protein function was tested with the luciferase 
refolding assay. Afterwards, aliquots were frozen in liquid nitrogen and stored at -
80°C. 
 
2.2.3.4 Luciferase refolding assay 
The firefly luciferase catalyses the conversion of luciferin to oxyluciferin, a 
reaction that is accompanied by the emission of light. If the luciferase is 
denatured, a functional Hsp70, Hsp40 and nucleotide exchange factor (NEF) are 
needed to refold the enzyme. The refolding process can then be visualised by the 
light emission that increases over time. A schematic overview of the luciferase 
refolding assay can be seen in Figure 10. 
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Figure 10 Schematic overview of the luciferase refolding assay 
The firefly luciferase (luci) converts its substrate luciferin to oxyluciferin by which light is emitted (1). If the 
firefly luciferase gets denatured by a short incubation at 40°C, the enzyme will be non-functional and no light 
will be emitted (2). The luciferase’s function can be restored by mixing the protein with a functional Hsp70, 
Hsp40 and nucleotide exchange factor (NEF) (3), which leads to the refolding and light will be emitted again 
(4). 
 
In this thesis, the assay was used to test whether the 2 purified untagged proteins 
HsHsp70wt and HsHsp70K71M were functional and non-functional, respectively. 
First, it was tested whether the firefly luciferase was functional. For this purpose, 
1 µL firefly luciferase was diluted in 124 µL refolding buffer (final concentration 80 
nM firefly luciferase). Afterwards, luciferase activity was assessed by a 
luminometer by adding 1 µL of the luciferase sample to 124 µL of assay buffer. In 
advance to each measurement, the luminometer injected 125 µL 80 µM luciferin. 
2*106-106 RLU (relative light units) were measured and set as 100% for 
normalisation. Afterwards, the luciferase was incubated at 40°C for 10 min and 
the denaturing process was controlled by measuring the RLU. After denaturing 
~104 RLU were set as the starting point (t0). The 80 nM of the denatured firefly 
luciferase were either mixed with 2 µM purified-untagged HsHsp70wt or the 
HsHsp70K71M and additionally 1 µM Hdj1, 0.2 µM Apg2 (both kind gifts from the 
AG Mayer, ZMBH) were added to 125 µL refolding buffer. The control did not 
contain any of the 2 purified HsHsp70s. The samples were incubated at 30°C and 
measurements were done in triplicates after 5, 10, 20, 30, 45, 60 and, 90 min. 
For each measurement 1 µL sample was diluted in 124 µL assay buffer. 
Material and methods 
38 
2.2.3.5 Dialysis 
Before the purified proteins were used for a growth assay, the storage buffer 
containing harmful chemicals for the parasite, e.g. beta-mercaptoethanol, was 
dialysed against PBS. Only a small volume of the protein was needed and in 
consequence, a special dialysing method was established for this. A normal 
Eppendorf tube was opened and with the help of a heated glass pasteur pipette a 
small whole was inserted in the lid of the tube. Afterwards, the dialysis membrane 
(Spectra/Por Dialysis Membrane, MWCO: 6-8 kDa) was soaked for several 
minutes in ddH2O. In the meantime, the protein was thawed on ice. Afterwards, 
the protein was transferred to the prepared Eppendorf tube and the dialysis 
membrane was pinched between the now “open” lid. Then, the Eppendorf tube 
was placed in a float and positioned in a beaker with PBS (1x) (100,000x more 
than protein volume). Before turning the float upside down, a little PBS was 
pipetted on the open lid to avoid air bubble formation. Finally, the protein was 
dialysed overnight in the cold room with a magnetic stirrer at a slow stirring 
speed.  
 
2.2.3.6 Fluorescent labelling of HsHsp70 
In order to study localisation of HsHsp70 in the non-infected as well as in infected 
erythrocytes, purified HsHsp70wt was fluorescently labelled by coupling the 
protein to a dye. For the labelling either Cy2 or Oregon-green were used. Pure 
untagged HsHsp70 was dialysed overnight. 2.8 mg protein was mixed with 0.3 
mg dye solved in 100% DMSO and incubated for 1 h in the dark. Afterwards, the 
PD Midi-Trap G-25 (GE, Healthcare) column was used to remove unbound dye 
according to the manufacturer’s instructions. Finally, the labelled proteins were 
separated on SDS-PAGE and protein labelling was controlled via a laser scanner 
at 488 nm. 
 
2.2.3.7 Resealing  
To assess the effect of HsHsp70 for parasite survival and development, 
erythrocytes were pre-loaded with an excess amount of a mutated HsHsp70-
protein. This pre-loading method is called resealing and is widely used in the 
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pharmacology to pre-load erythrocytes with drugs. In this approach, the 
erythrocytes are used as “carriers” to deliver drugs to the target site and thereby 
minimising the risk of side effects of the drug (Bourgeaux et al., 2016; Magnani et 
al., 1998, 2002; Rossi et al., 2005). This method was exploited to gain 
erythrocytes that were fluorescently labelled and contained an excess amount of 
HsHsp70K71M. The protocol was adapted from Frankland et al. 2006 and Bakar et 
al. 2010. In brief, erythrocytes were lysed via hypotonic lysis. Afterwards, the 
erythrocytes were mixed with a dye called rhodamine to label all cells that were 
successfully resealed. Furthermore, either the purified HsHsp70wt or the 
HsHsp70K71M was added or no protein, resulting in resealed RBC (rRBC) with 
HsHsp70wt/K71M or rRBC that were only pre-loaded with rhodamine (Figure 11).  
 
Figure 11 Overview of the resealing process 
Fresh RBC were lysed by hypotonic lysis. Afterwards, the lysed cells were mixed with rhodamine to label 
cells that were resealed. Further, HsHsp70
wt 
or HsHsp70
K71M
 pure untagged protein was added. In the end, 
either resealed RBC containing rhodamine (middle) or resealed RBC pre-loaded with rhodamine and 
HsHsp70
wt
 (left) or HsHsp70
K71M
 were produced. 
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During the test phase it was noted that the resealing process worked the best 
with freshly obtained blood not older than 24 h. In consequence, all resealing 
experiments were performed with freshly obtained blood. First, an ice cold master 
mix was prepared containing 5 mM sodium phosphate buffer (pH 7.4) with 20 mM 
glucose, 0.3 mM DTT, 1 mM Mg-ATP and 40 mg Rhodamine B isothiocyanate. 
5x109 freshly obtained erythrocytes were mixed with 4 times the volume of the 
master mix. Afterwards, the dialysed proteins were added. Usually, 120 µg of 
protein (HsHsp70wt or Hsp70K71M) was added per 5x109 packed erythrocytes. 
This resulted in a 1.5- to 1.8-fold HsHsp70 uptake compared to non-resealed 
(wildtype) erythrocytes (see Figure 18). Afterwards, the cells were lysed for 20 
min on ice while shaking. In order to avoid insufficient haemoglobin amounts after 
the resealing, an erythrocyte lysate was added. The lysate was prepared by 
repeated freezing and thawing of wildtype erythrocytes in liquid nitrogen. 
Afterwards, the lysate was centrifuged at 36,000xg for 10 min at 4°C. After cells 
lysis was completed, 1 mL of erythrocyte lysate was added and cells were 
resealed by the addition of 800 µL 37°C pre-warmed 1 M NaCl. Finally, cells were 
allowed to reseal for 1 h at 37°C. At the end, the resealed red blood cells (rRBC) 
were centrifuged at 2,100xg for 2 min with decreased brake (level 4 out of 9) and 
washed 3 times with complete RPMI. After the resealing the haemoglobin 
amount, the protein uptake and the resealing efficiency was checked. 
 
2.2.3.8 Measurement of haemoglobin 
After each resealing experiment the haemoglobin amount was checked. 
Therefore, rRBC were diluted 1:40 and 1:80 in RPMI. A sample of non-resealed 
(wildtype) erythrocytes was used as a control. 100 µL of the dilutions were 
pipetted into a 96-well-flat-bottom plate and the absorbance at 570 nm was 
measured. The absorbance of the non-resealed cells was set as 100% and the 
rRBC haemoglobin amount was calculated accordingly.  
 
2.2.3.9 Preparation of HuH7 western blot samples 
The downregulation of HsHsp70 in HuH7 cells using siRNA was checked by 
western blot. The cells were harvested 48 h post-transfection and washed twice 
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in ice cold PBS. Afterwards, 80 µL/well RIPA buffer with 1:200 PIC and 1 mM 
PMSF was added to the cells. The cells were incubated on ice for 15 min. Next, a 
pipette tip was used to scratch the cells from the plate and the samples were 
transferred to a tube. The collected cells were centrifuged at 36,000xg for 15 min 
and the supernatant was kept. Afterwards, total protein amount was determined 
using a plate reader. Then, the samples were complemented with 2x SDS 
loading dye, boiled at 100°C for 10 min and equal protein amounts around 10 µg 
were loaded on a 12% SDS gel.  
 
2.2.3.10 Preparation of RBC western blot samples 
For non-infected red blood cells, 107 cells were directly added to 2x SDS loading 
dye, boiled at 100°C for 10 min and centrifuged at 36,000xg for 10 min. 
Afterwards, 107 cells were loaded per lane on a 12% SDS gel. 
 
2.2.3.11 Sodium dodecylsulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
A sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
separates proteins according to their molecular weight. Every SDS gel consists of 
a stacking gel, which is used to concentrate the samples and a separating gel, 
which allows separation of proteins. The SDS gels used in this thesis were 
prepared according to the recipe in Table 12. 
Table 12 Composition of stacking and separation gel 
Component Stacking gel (5%) Separating gel (12%) 
ddH20 5.6 mL 7.6 mL 
Tris-HCl  2.5 mL 5 mL 
Acrylamide 1680 µL 7.4 mL 
APS 100 µL 160 µL 
 
The samples were prepared using 2x SDS loading dye and boiling for 10 min at 
100°C. The samples were separated at 90 V for 15-20 min until the samples 
entered the separating gel before increasing the voltage to 145 V for 1.5 h.  
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2.2.3.12 Coomassie blue gels 
After electrophoresis, proteins on SDS gels were visualised by Coomassie blue 
staining for 1 hour, followed by destaining using destain-solution. The destain-
solution was changed occasionally and ultimately replaced by ddH2O for further 
destaining overnight.  
 
2.2.3.13 Western blot 
In a western blot the protein of interest can be detected and quantified based on 
the interaction between antigen and antibody. First, proteins were separated by 
SDS-PAGE and transferred onto a nitrocellulose membrane (Towbin et al., 
1979). In the semi-dry blotting system a “sandwich” containing 3 blotting papers, 
the SDS gel, nitrocellulose membrane and 3 other blotting papers was 
assembled on a semi-dry blotter. Before setting up the blotting, all components of 
“the sandwich” were soaked in transfer buffer. The positive electrode was applied 
to the top of the semi-dry blotter and protein transfer was performed at 2 
mA/1cm2 for 1.5 h. After blotting, the membrane was blocked in 5% blocking milk 
for 1 h. The membrane was incubated overnight with the appropriate primary 
antibody diluted in 5% blocking-milk at 4°C. At the next day, the primary antibody 
was removed and the membrane was washed 3 times in PBS, 10 min each. 
Afterwards, the appropriate HRP conjugated secondary antibody (1:2,000 
dilution) in 5% blocking milk was added to the membrane for 2 h at RT. Next, the 
membrane was washed 3 times in PBS for 10 min. Afterwards, the membrane 
was placed in a developing cassette. Henceforth, all steps were performed in the 
dark. A mix of H2O2 and ECL (1:1,000 dilution) was added to the membrane. A 
photographic film was laid on the nitrocellulose membrane and closed for some 
seconds. Afterwards, the photographic film was placed in developer, water, 
fixation buffer, water and finally air-dried. 
 
2.2.3.14 ImageJ quantification of immunoblots 
To analyse the downregulation or protein uptake of HsHsp70, bands detected on 
the immunoblot where quantified using the freeware ImageJ. Therefore, the 
immunoblot photographic film was scanned at 600 dpi. Afterwards, the resulting 
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data file was opened with ImageJ and converted to the greyscale 8 bit format. 
The picture was calibrated by usage of the function “uncalibrated optical density”. 
Then, a square was used to enclose the band of interest and a measurement of 
the optical density (OD) was performed. The square was moved without changing 
the square’s size and the OD of the remaining bands was determined. In total 3 
independent measurements were performed. Finally, the downregulation or 
protein uptake was calculated normalised based on a loading control.  
 
2.2.3.15 Sera experiment 
To test whether different resealed host cells (with HsHsp70wt and HsHsp70K71M) 
have a different surface expression of e.g. PfEMP1, 2 sera (German naïve or a 
Pool of HyperImmune Sera (PHIS) from Kenya (kind gifts from AG Osier, 
Parasitology)) were incubated with infected rRBC. Afterwards, binding of 
antibodies in the sera was detected using anti-human IgG conjugated to Alexa-
488. For this experiment, resealed erythrocytes were infected with MACS purified 
trophozoites. 48 h post-invasion, 0.5 µL of 4-5% trophozoite culture, 1 µL sera 
and 11 µL 0.5% BSA in PBS were added to each well on a 96-well-U-bottom 
plate. The sera were incubated for 30 min at RT. Afterwards, cells were washed 3 
times in 200 µL 0.5% BSA in PBS and centrifuged at 800xg for 3 min. The wash 
buffers were discarded by flipping the plate over the sink to avoid cell loss. Then, 
the second antibody staining was performed using a 1:50 dilution of mouse-anti-
human-Alexa-488 for 30 min at RT in the dark. Cells were washed 3 times in 200 
µL 0.5% BSA in PBS with 800xg for 3 min. Finally, the cells were fixed in 4% PFA 
in PBS at 4°C overnight and samples were prepared for flow cytometry. As a 
control, non-infected RBC were used to exclude unspecific binding of the 
antibodies due to any reaction of the host RBC with the naïve serum and PHIS 
sera. Furthermore, a background control of infected rRBC, which was only 
stained with the secondary antibody, was included. 
 
2.2.3.16 Indirect immunofluorescence assay 
The indirect immunofluorescence assay exploits the specific recognition of an 
antigen by an antibody. Thereby, localisation of a certain protein can be 
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determined and even co-localisation studies can be performed. First, a methanol 
fixation in ice-cold 10% methanol and 90% acetone was performed. Parasite 
smears were carried out on a slide and samples were fixed for 10 min in the 
acetone/methanol mixture at -20°C. The blocking was performed using 3% BSA 
in PBS for 1 h. Afterwards, the primary antibody was diluted in 3% BSA in PBS 
and incubated overnight at 4°C in a wet chamber. On the next day, slides were 
washed 3 times in PBS and the appropriate secondary antibody was diluted in 
3% BSA and incubated for 2 h at RT. Following, the slides were washed 3 times 
in PBS and the nuclear staining was performed using DAPI. To this end, slides 
were incubated with 1 µg/mL DAPI in PBS for 10 min. At last, slides were washed 
once with ddH2O to remove salt crystals from the PBS and analysed by 
fluorescence microscopy at a 63x objective magnification with immersion oil.  
 
2.2.4 Analysis of Parasite Growth  
2.2.4.1 Setting up the growth assay 
All growth assays were performed in 96-well flat-bottom plates. One well 
contained 200 µL RPMI complete medium with a 2% haematocrit and 0.1% 
starting parasitemia. The growth was analysed by either a LDH assay (2.2.4.2) or 
by flow cytometry (2.2.4.3) after 48 h and 96 h. Several controls were included in 
the setup. The first control was a sample of non-infected RBC acting as a 
background control for the LDH assay or for the DAPI/SYBR green staining. 
Further, parasites were treated with 50 µg/mL BFA acting as positive control 
showing parasite death.  
 
2.2.4.2 Lactate dehydrogenase assay 
The LDH assay exploits the ability of plasmodial lactate dehydrogenase (pLDH) 
to convert lactate to pyruvate (Basco et al., 1995) with the help of the cofactor 3-
acetylpyridine adenine dinucleotide (APAD+), which is reduced to APADH. Upon 
the addition of the yellow dye nitroblue tetrazolium (NBT) and diaphorase (also 
called lipoamide dehydrogenase), the APADH is oxidised to APAD+ while NBT is 
converted to the coloured product formazan (Markwalter et al., 2016). The 
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harvest was performed at the trophozoite stage after 48 h and 96 h. To harvest 
the cells for the LDH assay, 100 µL of the used medium was removed and 
parasites were resuspended in the remaining medium. Afterwards, parasites 
were frozen at -20°C for at least 24 h. For the LDH assay 50 mL LDH-buffer was 
used to dissolve 1 Nitro Blue Tetrazoilum (NBT) tablet (in the dark). Afterwards, 
the LDH-NBT buffer was complemented with diaphorase from Clostridium 
kluyveri (final concentration 1U/mL) and 3´-acetylpyridine adenine dinucleotide 
(APAD) (final concentration 50 µg/mL). The parasites were thawed for 30 min at 
RT and then, mixed 1:1 with the prepared LDH-buffer. The reaction was 
incubated at RT in the dark for 20 min. Afterwards, the reaction was measured at 
A650 nm using a plate reader. 
 
2.2.4.3 Flow cytometry analysis 
All flow cytometry measurements were performed at the ZMBH FACS core facility 
under the supervision of Dr. Monika Langlotz. The BD Canto uses the BD Diva 
software for analysis. Depending on the experiments gates were set with the 
appropriate controls and lasers (e.g. 561-C, 408-B, 488-B). All experiments were 
measured in 96-well U-bottom plates with 200 µL using the HTS loader. HTS 
loader settings were as following: sample flow rate (0.5 µL/s), sample volume 
(160 µL), mixing volume (100 µL), mixing speed (180 µL/s), number of mixes (4) 
and, wash volume (400 µL). After measuring the data was saved as PDF as well 
as FCS file, which was then further analysed using the FlowJO software (version 
10.4.2). 
 
2.2.4.3.1 Preparation of HuH7 Plasmodium berghei infected flow cytometry 
samples 
48 h post-infection with P. berghei liver stages, the cells were harvested for flow 
cytometry. The cells were washed twice with DMEM incomplete (no FCS) 
medium and 80 µL trypsin/EDTA was added for 3-5 min. For inactivation 160 µL 
DMEM complete was added and cells were transferred to a tube. The samples 
were centrifuged at 600xg for 2 min and washed once in 200 µL 1x PBS. Finally, 
cells were resuspended in 400 µL 1x PBS and transferred into FACS tubes. 
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2.2.4.3.2 Preparation of Plasmodium falciparum iRBC flow cytometry 
samples 
The growth of P. falciparum in the different resealed host cells was analysed by 
flow cytometry. After 48 h and 96 h at the trophozoite stage parasites were fixed. 
To this end, the 200 µL spent culture medium was replaced with 100 µL 4% PFA 
with 0.0075% Glutardelyhde and fixed overnight at 4°C. At the next day, samples 
were either DAPI stained or stained with SYBR green to allow for differentiation 
of the ring/trophozoite or schizont stages. 
DAPI staining:  
Parasites were washed in PBS after fixation and then DAPI stained with 1 µg/mL 
DAPI in PBS for 10 min. Afterwards, the 96 well plate was centrifuged at 1,000xg 
for 2 min and 5 times washed in 150 µL PBS. Finally, cells were resuspended in 
200 µL fresh PBS. Lastly, cells were diluted 1:6 in a fresh 96-well U-bottom plate 
with 200 µL PBS.  
SYBR green staining: 
For SBYR green staining cells were washed once in PBS and then resuspended 
in 100 µL (1:2,000) SYBR green. Afterwards, cells were washed 3 times in 150 
µL PBS and finally diluted 1:6, as described for the DAPI staining. 
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3 Results 
3.1 Establishing the resealing method 
In this study, the role of HsHsp70 for the intra-erythrocytic development of P. 
falciparum was elucidated. Unfortunately, human erythrocytes cannot be easily 
genetically modified to study the effect of a certain host protein on parasite 
survival and development. In consequence, a different approach was needed. 
Here, a pre-loading or also called resealing method of human mature 
erythrocytes, which is widely used in the pharmacology, came in handy 
(Bourgeaux et al., 2016; Magnani et al., 1998; Rossi et al., 2005). Erythrocytes 
can be lysed and pre-loaded with e.g. an excess amount of a mutated protein of 
interest, leading to a classical dominant negative. In this thesis, a non-functional 
HsHsp70 called HspHsp70K71M (unable to hydrolyse ATP) (O’Brien et al., 1996) is 
added during the resealing, thereby resealed red blood cells (rRBC) loaded with 
an excess amount of HspHsp70K71M are produced that can be used as host cells 
for the infection with parasites. As a control, rRBC were pre-loaded with a 
functional HsHsp70 called HsHsp70wt protein. In the beginning, various resealing 
protocols and methods were tested. Each method contained major drawbacks 
considering the resealing efficiency and the reproducibility (data not shown). After 
a long test phase, the combination of several resealing protocols led to satisfying 
results. During this test phase a dye called rhodamine was added, without adding 
any HsHsp70 protein, to check the pre-loading. In the end, rRBC were analysed 
by fluorescence microscopy. Indeed, using the newly established protocol, rRBC 
showed fluorescence labelling (Figure 12). 
 
Figure 12 Fluorescence microscopy of resealed red blood cells (rRBC) 
Microscopy of non-fixed and non-infected rRBC labelled with rhodamine. DIC: Differential Interference 
Contrast, 63x objective magnification. 
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After establishing the resealing method it was tested, whether the rRBC were still 
susceptible to P. falciparum infection. Therefore, parasites expressing a cytosolic 
Green Fluorescent Protein (GFP) were enriched by Magnetic Activated Cell 
Sorting (MACS) to a parasitemia of nearly 100%, thereby avoiding that non-
infected erythrocytes from the culture were diluting the rRBC. 48 h post-invasion, 
rRBC were checked by live cell imaging. As seen in Figure 13, GFP-expressing 
parasites infected the rhodamine labelled rRBC and even double infections of 
rRBC were observed (Figure 13). Interestingly, the rhodamine signal co-localised 
with hemozoin, characteristic of the food vacuole, thereby indicating that the 
rhodamine was located in the food vacuole of the parasite. 
 
Figure 13 Resealed red blood cells infected with parasites expressing GFP 
Live cell imaging of rRBC labelled with rhodamine and infected with P. falciparum parasites expressing GFP. 
DIC: Differential Interference Contrast, ET: Early Trophozoite, T: Trophozoite, GFP: Green Fluorescent 
Protein, 63x objective magnification.  
 
Next, the protein purification of the 2 proteins needed for the dominant negative 
effect was performed. During the resealing process either the mutated 
HsHsp70K71M or the wildtype HsHsp70wt was used. The latter acted as a positive 
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control. The 2 His-SUMO-tagged proteins were expressed in E. coli and purified 
by affinity chromatography. Finally, the His-SUMO-tag was removed by the Ulp1-
protease. The 2 untagged proteins were separated on a SDS-PAGE and stained 
with Coomassie. Both proteins presented pure protein bands around 70 kDa 
(Figure 14).  
 
Figure 14 SDS-PAGE of HsHsp70
wt
 and HsHsp70
K71M
 
Pure and untagged HsHsp70
wt 
and HsHsp70
K71M
 separated on a 12% SDS-PAGE. Bands were visualised 
with Coomassie staining. Size marker indicated on the left side in kDa.  
 
Following purification, both purified proteins were checked for contamination with 
E. coli Hsp70, called DnaK, which often is found as contaminant. The purified 
proteins as well as an E. coli protein lysate used as positive control for DnaK 
were separated by SDS-PAGE. Afterwards, an immunoblot analysis using 
antisera raised against DnaK was carried out. DnaK was only detected in the 
positive control (E. coli lysate) around 70 kDa, but was absent in the HsHsp70wt 
and HsHsp70K71M, indicating the purity of the 2 protein samples (Figure 15A). As 
a loading control, the same samples were analysed by immunoblot using antisera 
directed against HsHsp70. The positive control (RBC) as well as the purified 
proteins showed bands around the expected 70 kDa (Figure 15B). 
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Figure 15 Immunodetection of DnaK and HsHsp70 
(A) Immunoblotting against DnaK with E. coli lysate, 10
7
 non-infected RBC, HsHsp70
wt
 and HsHsp70
K71M
. 
(B) Immunoblotting against HsHsp70 with E. coli lysate, 10
7
 non-infected RBC, HsHsp70
wt
 and 
HsHsp70
K71M
. 
Size markers indicated on the left side in kDa. 
 
To assess whether the purified proteins were functional and non-functional, a 
luciferase refolding assay was conducted. Briefly, the function of a denatured 
firefly luciferase can be restored by the refolding capacity of an active Hsp70 in 
concert with its co-chaperone Hsp40 and the help of a NEF. The denatured firefly 
luciferase was incubated with an Hsp40, a NEF (both kind gifts from Dr. Roman 
Kityk, research group Mayer, ZMBH) and either the functional HsHsp70wt or the 
inactive HsHsp70K71M. The control sample did not contain either of the 2 proteins. 
The refolding was visualised by light emission, which was monitored over 90 
minutes. Only HsHsp70wt was able to refold the luciferase, whereas both the 
control and the inactive mutant HsHsp70K71M displayed only small to no refolding 
capacity (Figure 16). In the literature usually up to 80% of luciferase refolding is 
reported (Morán Luengo et al., 2018; Schröder et al., 1993). Here, only a smaller 
refolding was achieved, but a similar trend could be observed upon the addition 
of a functional HsHsp70wt. In consequence, a pure, untagged and functional 
HsHsp70wt as well as non-functional HsHsp70K71M have been purified.  
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Figure 16 Luciferase refolding assay with HsHsp70
wt
 and HsHsp70
K71M 
The blot shows relative refolding over time of denatured firefly luciferase with HsHsp70
wt
 or HsHsp70
K71M
, 
Hsp40 and NEF. The control did not contain either one of the 2 purified proteins. The highest measured 
relative light unit was set as 100% to calculate the relative refolding in percent. Result of 1 experiment in 
triplicates.  
 
Next, the average protein amount of HsHsp70 in mature human erythrocyte was 
determined. Therefore, 107 RBC were separated on a SDS-PAGE together with 
20, 40 and 100 ng of purified HsHsp70. Immunoblotting against HsHsp70 was 
used to visualise the proteins and protein quantification was performed with the 
freeware ImageJ. The measurement indicated that 107 erythrocytes contained 
approximately 10 ng HsHsp70 (Figure 17A). Afterwards, it was verified whether 
Hsp70wt and HsHsp70K71M can be successfully entrapped into the rRBC. Based 
on the determined amount of endogenous HsHsp70, different concentrations of 
HsHsp70wt/K71M were added during the resealing to achieve a double to triple 
protein excess for the dominant negative effect. The protein uptake was 
confirmed by immunoblotting (data not shown). In the end, approximately 80 ng 
of purified protein were added per 107 erythrocytes, which presented intensive 
bands in the immunoblot. The exact amount of HsHsp70 entrapped in RBC was 
determined by immunoblotting. First, RBC, rRBC with no protein and rRBC with 
HsHsp70wt (HsHsp70wt) or with HsHsHspK71M (HsHsp70K71M) were subject to 
SDS-PAGE, followed by an immunoblot against HsHsp70 and Glycophorin A&B. 
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The latter acted as loading control (Figure 17A). Afterwards, the quantification 
with ImageJ revealed that rRBC contained little less HsHsp70 compared to the 
wildtype RBC. However, protein uptake during the resealing of HsHsp70wt/K71M 
was confirmed and was determined to approximately 30 ng of HsHsp70 for both 
proteins (Figure 17B). Furthermore, the amount of the cognate form HsHsc70 
was determined. Therefore, the same samples were separated by SDS-PAGE 
followed by immunoblotting against HsHsc70 (Figure 17C). ImageJ quantification 
indicated that the HsHsc70 amounts were similar in all 4 samples (Figure 17D). 
Additionally, both HsHsp70 and HsHsc70 antisera were tested for their specificity 
with purified HsHsp70 and HsHsc70 recombinant proteins (shown in the 
appendix, Figure 44).  
 
Figure 17 Immunodetection of HsHsp70 and HsHsc70 with ImageJ quantification 
(A) Immunoblot against HsHsp70 with RBC, rRBC and rRBC with HsHsp70
wt
 or HsHsp70
K71M
 as well as 20, 
40,100 ng purified HsHsp70. Glycophorin A&B was used as a loading control. Size markers are 
indicated on left side in kDa. 
(B) ImageJ quantification of HsHsp70 in ng based on (A). The amount of HsHsp70 was determined 
according to the standard curve of 20-100 ng purified HsHsp70. Result of 1 quantification. 
(C) Immunoblot against HsHsc70 with RBC, rRBC and rRBC with HsHsp70
wt
 or HsHsp70
K71M
 and 
Glycophorin A&B (loading control). Size markers are indicated on left side in kDa. 
(D) Dot blot with boxes shows relative percent of HsHsc70 determined by ImageJ quantification of (C). 
Relative percent of HsHsc70 was normalised against Glycophorin A&B. Results of 4 independent 
resealing experiments. 
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It was shown in previous translocation experiments, using the same dominant 
negative approach, that HsHsp70 has an important impact on the transport of 
parasite proteins across the PVM (Günnewig, 2016). Thus, it was tested with 
immunoblotting whether a similar HsHsp70 fold increase was obtained due to the 
resealing as for the translocation assay. Therefore, wildtype erythrocytes, rRBC 
and rRBC with HsHsp70wt or HsHsp70K71M were separated on a SDS-PAGE 
followed by immunoblotting against HsHsp70 and Glycophorin A&B as a loading 
control (Figure 18A). Afterwards, the visualised bands were quantified by ImageJ. 
An approximately 2-fold increase in the HsHsp70 concentration compared to 
wildtype erythrocytes was measured for HsHsp70wt and HsHsp70K71M (Figure 
18B). The direct comparison between the resealing and the translocation assay 
can be seen in Figure 18C. In the resealing assay, the amount of HsHsp70 was 
compared to the rRBC, whereas in the translocation assay the amount of 
HsHsp70 was compared to the positive control of the assay, where no HsHsp70 
was added. Both assays achieved an approximate 6-fold increase of 
HsHsp70wt/K71M (Figure 18C). Therefore, the resealing experiments and the 
translocation assays used equal protein amounts for the dominant negative 
effect. At last, the haemoglobin amount in the 3 different resealed cell types was 
checked, as any variation might affect the expected growth. The haemoglobin 
amount was determined by measuring the absorbance at 570 nm, while setting a 
sample of wildtype erythrocytes (non-resealed) as 100% and calculating the 
respective percentages for the rRBC samples. In general, similar amounts of 
~40% haemoglobin were achieved for all 3 samples (Figure 18D). 
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Figure 18 Protein uptake and haemoglobin concentration in rRBC 
(A) Immunoblot against HsHsp70 with RBC, rRBC and rRBC with HsHsp70
wt
 or HsHsp70
K71M
 and 
Glycophorin A&B was used a loading control. Size markers are indicated on left side in kDa. 
(B) Dot blot with box presents HsHsp70 amount in fold compared to wildtype erythrocytes normalised 
against Glycophorin A&B determined by ImageJ quantification of (A). Results of 9 independent resealing 
experiments. 
(C) Dot blot with box visualising HsHsp70 amount in resealing and translocation assays (Günnewig, 2016). 
For the resealing HsHsp70 amounts were calculated in comparison of rRBC. The HsHsp70 amount in 
the translocation assay was calculated in comparison to the positive control of the assay.  
(D) Haemoglobin amount in percent of rRBC and rRBC with HsHsp70
wt
 or HsHsp70
K71M
 compared to non-
resealed wildtype erythrocytes. 
 
To sum everything up, a successful resealing protocol was established enabling 
the pre-loading of mature human erythrocytes. With this method cells were 
resealed and were still capable of being infected by P. falciparum. During the 
resealing the pure, untagged functional HsHsp70wt and inactive HsHsp70K71M can 
be entrapped into the rRBC, resulting in a 6-fold excess compared to rRBC 
where no protein was added. All 3 rRBC contained ~40% haemoglobin compared 
to wildtype erythrocytes that were non-resealed.  
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3.2 Localisation of HsHsp70 in non-infected and infected erythrocytes 
Apart from the investigation of HsHsp70 for parasite survival and development, 
analysing the localisation of HsHsp70 was also of interest. In previous studies, 
several fruitless attempts were made to localise HsHsp70 in non-infected as well 
as in the infected erythrocyte using classical immunofluorescence assays (Jude 
Przyborski, personal communication). Here, the resealing method was used to 
entrap fluorescently labelled HsHsp70 to the mature human erythrocytes, to 
localise the protein in the non-infected erythrocyte. To achieve this, the purified 
HsHsp70wt was coupled to an Oregon green dye and as a control Bovine Serum 
Albumin (BSA) was coupled to Oregon green, as well. Afterwards, HsHsp70wt-
Oregon green, BSA-Oregon green and a sample of the dye itself were separated 
by SDS-PAGE and bands were visualised with the help of a laser scanner. 
Indeed, protein labelling was confirmed by an intensive band around the 
expected 70 kDa for HsHsp70wt-Oregon green and for the control BSA-Oregon 
green.  
 
Figure 19 Labelling of HsHsp70
wt
 and BSA with Oregon green 
HsHsp70
wt
-Oregon green, BSA-Oregon green and Oregon green dye were separated on a 12% SDS gel 
and bands were visualised using a laser scanner at 488 nm. Size markers are indicated on left hand side in 
kDa. 
 
After confirming the coupling of the proteins to the dye, 3 resealing reactions with 
mature human erythrocytes were performed using either HsHsp70wt-Oregon 
green, BSA-Oregon green, or only the dye. Moreover, for all 3 reactions 
rhodamine was added to label cells that were resealed. Afterwards, rRBC were 
analysed by fluorescence microscopy for the localisation of the proteins. The 
HsHsp70wt-Oregon sample displayed dot-like structures all over the non-infected 
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cell. At a closer look, the dot-like structures were mobile foci presenting no 
directed movement, but rather a randomised motion. However, BSA-Oregon as 
well as the dye itself displayed an equal fluorescence throughout the cytosol in 
accordance to the rhodamine signal (Figure 20).  
 
Figure 20 Fluorescence microscopy of HsHsp70
wt
-Oregon green in non-infected rRBC 
Live cell imaging of HsHsp70
wt
-Oregon green (HsHsp70
wt
), BSA-Oregon green (BSA), and dye (dye) in 
rRBC. 63x objective magnification, DIC: Differential Interference Contrast. 
 
After localising HsHsp70 in the non-infected erythrocyte, its localisation in the 
infected erythrocytes was investigated. Unfortunately, the previously used 
Oregon green dye was emptied and due to time restriction HsHsp70 was labelled 
with another available Cy2 dye. First, HsHsp70 coupling to Cy2 was verified 
using the laser scanner. HsHsp70 labelling was confirmed by the presence of an 
intense band around the expected 70 kDa (Figure 21). 
Results 
57 
 
Figure 21 Labelling of HsHsp70
wt 
with Cy2 
HsHsp70
wt
-Cy2 separated on a 12% SDS-gel visualised by typhoon laser scanner at 488 nm. Size markers 
are indicated on left hand side in kDa. 
 
Next, a resealing in presence of the HsHsp70wt-Cy2 was performed and rRBC 
were infected with MACS purified P. falciparum wildtype parasites. After 48 h, 
rRBC with HsHsp70wt-Cy2 were subjected to life cell imaging. Uninfected rRBC 
were used as a control and the incorporation of HsHsp70wt-Cy2 was checked, 
revealing the same dot-like structures as observed for the HsHsp70wt-Oregon 
green labelling. Contrary to the initial expectations, HsHsp70wt-Cy2 was identified 
inside the parasite and not in the host cell.  
 
Figure 22 Live cell imaging of HsHsp70
wt
-Cy2 in rRBC 
Live cell imaging of HsHsp70
wt
-Cy2 in the non-infected rRBC (rRBC) and the infected rRBC (irRBC). 63x 
objective magnification, DIC: Differential Interference Contrast. 
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Inevitably, no progress on the localisation of HsHsp70 in the infected erythrocyte 
was made with the resealing and in consequence, another approach was 
needed. The new idea was to genetically modify P. falciparum in a way, leading 
to the parasite itself exporting a tagged HsHsp70 to its own host cell, which would 
enable the localisation of the protein. Thus, a construct containing the first 80 
amino acids of STEVOR (a known exported protein of the parasite, with the first 
80 amino acids being sufficient to direct any protein to the host cell), an mCherry 
tag allowing the localisation of the fusion protein as well as the full sequence of 
HsHsp70 was introduced into the parasite (Figure 23A). Transfection of the 
parasites was successful and parasites showed a detectable mCherry signal 
upon live cell imaging. Similarly, to the localisation experiments using the 
resealing, the infected erythrocytes showed mobile dots (data not shown), as 
well. Unfortunately, the signal was not strong enough to acquire good pictures 
and consequently an ImmunoFluorescence Assay (IFA) was performed using 
antisera directed against mCherry. The fusion protein localised to the host cell 
cytosol displaying a dot-like structure. Some of the protein was localised inside of 
the parasites, leading to the presumption that protein export was not complete 
(Figure 23B).  
 
Figure 23 HsHsp70
mCherry
 in the infected erythrocyte 
(A) Construct of STEVOR 1-80 with mCherry and HsHsp70. 
(B) Immunofluorescence assay against mCherry showing the fusion protein HsHsp70
mCherry
. Nucleus 
visualised with DAPI. As a negative control the fixed cells were stained with the secondary antibody, 
which did not show any fluorescence. 63x objective magnification, DIC: Differential Interference 
Contrast. 
 
There are already 2 known dot-like structures described in the infected 
erythrocyte. The so called J-dots, which contain parasite encoded chaperones 
and co-chaperones, appear as mobile dot-like structures in the infected RBC. 
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Further, Maurer’s clefts, which are single membrane structures close to the host 
cells, also show punctuate structures in the infected erythrocyte and even present 
motion in younger trophozoite stages. Hence, it was analysed whether the 
HsHsp70mcherry fusion protein co-localised with any of the known structures. 
Therefore, co-localisation studies with antisera directed against mCherry and 
either Hsp70x ((70x), a parasite-encoded and exported chaperone, J-dot marker) 
(Külzer et al., 2012) or SBP1 (a known component of the Maurer’s clefts) 
(Blisnick et al., 2000) was performed. The J-dot marker 70x showed the expected 
dot-like structures and surprisingly, a partial co-localisation could be detected. 
The Maurer’s cleft marker SBP1 did not demonstrate co-localisation with 
HsHsp70mcherry (Figure 24). 
 
Figure 24 Co-localisation study of HsHsp70
mCherry
 with 70x and SBP1 
Co-localisation study of HsHsp70
mcherry
 with the J-dot marker 70x and the Maurer’s cleft marker SBP1. 
Pictures below merge show close up from the indicated boxes. Staining with the secondary antibodies did 
not present fluorescence. 63x objective magnification. 70x: PfHsp70x, SBP1: Skeleton-Binding Protein 1, 
DIC: Differential Interference Contrast. 
 
To sum up, the results of the localisation study using the resealing approach 
presented HsHsp70 as mobile foci in the non-infected erythrocyte, but also 
revealed in addition to the immunoblots that protein uptake during the resealing 
was achieved. However, regarding the localisation of HsHsp70 in the infected 
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erythrocyte, no satisfying results were obtained. Still, HsHsp70mCherry expression 
and the export of the protein to the host cell was possible. The fusion protein 
displayed a dot-like structure in the infected RBC, which partially co-localised with 
the J-dot marker Hsp70x, but not with the Maurer’s clefts marker SBP1.  
 
3.3 Growth analysis of HsHsp70 in 3D7 wildtype parasites 
After showing that rRBC can be pre-loaded with an excess amount of HsHsp70 
and can still be infected by P. falciparum, the role of the host cell protein in the 
intra-erythrocytic development of the parasite was analysed. First, a classical 
growth assay followed by a Lactate DeHydrogenase assay (LDH) was performed. 
In this study, several rRBC types were analysed for growth; (i) rRBC pre-loaded 
with no additional protein, (ii) rRBC pre-loaded with an excess amount of 
HsHsp70wt and (iii) rRBC with an excess amount of the inactive HsHsp70K71M. All 
3 host cell types were infected with MACS purified 3D7 wildtype parasites. 
Further, non-infected rRBC samples were included, acting as background control 
for the LDH assay. At last, a control of BFA, a substance that causes the death of 
the parasite, was added to the experimental setup. Parasite growth was 
monitored for 48 and 96 h and analysed using the LDH assay. The LDH assay 
exploits the anaerobic metabolism of the parasite, which includes the conversion 
of lactate to pyruvate and can be visualised upon the addition of a yellow 
substrate that is converted into a product of blue-brownish colour (Markwalter et 
al., 2016). The colorimetric assay was measured using a laser at 650 nm, with the 
absorbance at this wavelength being proportional to the parasitemia. The results 
of 4 independent LDH assays after 48 h and 96 h can be seen in Figure 25. After 
48 h, the BFA control worked well for all 3 samples and showed low relative 
absorbance, indicating the death of the parasites. However, some assays 
showed decreased growth for parasites grown in either the presence of 
HsHsp70wt or HsHsp70K71M. Overall, there were statistically significant differences 
for HsHsp70wt and HsHsp70K71M compared to the rRBC control. Incubation for 96 
h displayed big variations for the growth of HsHsp70wt and HsHsp70K71M 
samples. Here, a significantly smaller growth rate in the rRBC containing 
HsHsp70K71M was observed (Figure 25).  
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Figure 25 Lactate dehydrogenase assay of 3D7 grown in rRBC  
LDH assay of 3D7 parasites grown in rRBC, rRBC pre-loaded with an excess amount of HsHsp70
wt
 or 
HsHsp70
K71M
. Parasites were treated with BFA (50 µg/mL) as a positive control for parasite death (BFA). 
Absorbance at 650 nm in percent of 4 independent experiments is visualised. The relative absorbance was 
calculated based on the highest absorbance in the single assays. Background of non-infected rRBC, 
HsHsp70
wt
 and HsHsp70
K71M
 were subtracted, respectively. The mean values are indicated by a red dash 
and statistical significance was determined by the One-Way ANOVA-Holm Sidak test.  
 
Using the LDH assay no consistent results were obtained due to limitations of the 
assay. With the LDH assay no distinction between non-resealed and resealed 
cells was made. Nevertheless, resealing efficiencies may differ between the 3 
rRBC types and can thereby already influence the results. In consequence, the 
next step was to adjust the read-out method to flow cytometry. Here, the growth 
of only successfully resealed RBC was analysed by assistance of the rhodamine 
labelling and parasites can be easily visualised by a DAPI staining. The same 
experimental setup as previously explained for the LDH assay was used, but 
growth was now analysed by flow cytometry with some smaller adjustments. The 
parasites were fixed using 4% ParaFormAldehyde (PFA) in PBS and stained with 
DAPI. Additionally, the study was blind, therefore, each resealing protein name 
was coded during the process. 
First, controls were used to set the gates for the analysis. With the help of non-
infected and non-resealed wildtype erythrocytes (RBC) the gate for rhodamine 
positive cells was set. Next, a sample with rRBC that were non-infected, but 
stained with DAPI was used to confirm the rhodamine gate and to set the gate for 
the DAPI positive cells. At last, the gating process was checked by infected 
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rRBC, which were stained with DAPI (irRBC DAPI) (Figure 26). In the appendix 
an example for the gating strategy with the FlowJo software can be seen 
(appendix Figure 45). 
 
Figure 26 Gating strategy of DAPI positive cells in rRBC 
Flow cytometry gating strategy of DAPI positive cells detected in rRBC. Non-infected and non-resealed RBC 
(RBC) were used to set the gate for rhodamine positive cells. rRBC non-infected but stained with DAPI were 
used as a control for the DAPI gating. Finally, infected rRBC stained with DAPI were used to confirm the 
gating strategy.  
 
After 48 h parasites presented less growth in the presence of HsHsp70K71M 
compared to rRBC, although not significant. Interestingly, the growth rate in the 
rRBC with HsHsp70wt was significantly increased compared to the rRBC control 
after 96 h. The BFA controls after 48 h and 96 h showed low relative growth. For 
all samples, a DAPI background control with non-infected DAPI stained rRBC 
was included. Sometimes the measured background was higher compared to the 
actual parasitemia obtained for BFA treated samples, explaining the negative 
values seen for the BFA controls (Figure 27).  
Results 
63 
 
Figure 27 3D7 growth in rRBC with HsHsp70
wt
 and HsHsp70
K71M
 
Flow cytometry assay of 3D7 parasites grown in rRBC, rRBC containing an excess of HsHsp70
wt
 or 
HsHsp70
K71M
. As a positive control for parasite death, parasites were treated with BFA (50 µg/mL) (BFA). 
The relative growth in percent was determined by setting highest parasitemia of the single assay as 100%. 
Background of non-infected rRBC, HsHsp70
wt
 and HsHsp70
K71M
 stained with DAPI were subtracted, 
respectively. The mean values are indicated by a red dash and statistical significance was determined by the 
One-Way ANOVA-Holm Sidak test.  
 
As there was no statistically significant effect on the growth of the parasite in the 
presence of an excess amount of HsHsp70K71M, the developmental stages of the 
parasites were analysed in more detail using a SYBR green staining. The 
staining of the fixed parasites enabled differentiation between the single-
nucleated stages of the parasite, the ring and trophozoite stage, and the multi-
nucleated schizont stage. 
Again, proper gating was ensured as for the DAPI analysis and non-infected and 
non-resealed cells (RBC) were used to set the gate for rhodamine cells. This 
time, non-infected and SYBR green stained rRBC were used set the gate for 
SYBR green positive cells. Finally, a sample of rRBC infected with mixed stages 
(ring, trophozoite and schizont) acted as a control for the ring/trophozoite gate 
(RT) and the schizont (S) gate (Figure 28). In the appendix, Figure 45 shows an 
example for the gating process. 
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Figure 28 Gating strategy for SYBR green positive cells in rRBC 
Flow cytometry gating strategy of SYBR green (SG) positive cells detected in rRBC to differentiate single-
nucleated ring/trophozoites (RT) and multi-nucleated schizonts (S). Non-infected and non-resealed RBC 
(RBC) were used to set gate for rhodamine positive cells. Non-infected but SYBR green stained rRBC acted 
as a control for the SYBR green gating. Finally, infected rRBC stained with mixed stages were used to set 
the gates for the ring/trophozoites (RT) and for schizonts (S). 
 
Again, rRBC and rRBC with HsHsp70wt/K71M were infected with MACS purified 
3D7 wildtype parasites and fixed after 48 and 96 h. Afterwards, the cells were 
stained with SYBR green and analysed by flow cytometry. No difference for ring 
and trophozoite stages (RT) was observed between the samples. However, 
HsHsp70K71M presented significantly less schizonts compared to the rRBC 
control. 96 h post-infection, no statistical difference was detected between 
parasites grown in the different host cell types. Tough, the power of the 
performed statistical test was below the desired one and a smaller power 
indicates that it is less likely to detect a difference when one actually exists. 
There are big variances in the obtained data, in particular for the determined RT 
numbers, and in general more repeats are needed to validate the results.  
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Figure 29 Analysis of ring/trophozoite and schizont stages in rRBC with HsHsp70
wt
 and HsHsp70
K71M
 
Flow cytometry assay of 3D7 parasites grown in rRBC, rRBC with HsHsp70
wt
 and rRBC with HsHsp70
K71M
. 
Dot blot with box shows relative percent of SYBR green positive cells from 2 independent experiments. The 
relative percent of SYBR green positive cells was calculated based on the highest parasitemia in the single 
assays. Background of non-infected rRBC, HsHsp70
wt
 and HsHsp70
K71M
 stained with SYBR green were 
subtracted, respectively. The mean values are indicated by a red dash and statistical significance was 
determined by the One-Way ANOVA-Holm Sidak test.  
 
Even if there are no detectable differences in the intra-erythrocytic development, 
protein export and thereby the surface expression of major cytoadherence 
proteins might still be altered. Usually, differences on the surface of the infected 
erythrocyte are analysed using a binding assay. Unfortunately, the rRBC limit the 
portfolio of classical methods used for normal infected erythrocytes. During the 
study it was noted that rRBC react more sensitive to e.g. PFA fixation. As a 
result, the rRBC protein surface expression was analysed using 2 different sera. 
A Pool of HyperImmune Sera (PHIS) from the endogenous malaria region Kelifi, 
Kenya (kind gift from Dr. Osier, Parasitology, Heidelberg) was used. It is already 
well-established to use such sera from endemic malaria regions to recognise 
surface antigens on the infected erythrocyte (Maier et al., 2008). Mostly EMP1 is 
recognised by such sera (Beeson et al., 2006). In this study, naïve serum from 
Germany obtained from donors who did not acquire any immunity against malaria 
acted as negative control. The 3 different rRBC types were infected with MACS 
purified wildtype 3D7 parasites. After 48 h, parasites were incubated either with 
the PHIS or the naïve serum. The antibodies bound to the surface of the irRBC 
were visualised by an anti-human-Alexa-488 staining. After intensive washing, 
the parasites were fixed in 4% PFA and subject to flow cytometry analysis.  
Results 
66 
First, gates were set by usage of the proper controls. Again, non-resealed 
erythrocytes were used set the gate for the rhodamine positive cells. Afterwards, 
a sample of non-infected but DAPI stained erythrocytes secured the gating for 
DAPI positive cells. The gate for Alexa-488 positive cells was set with the help of 
infected rRBC stained by DAPI and incubated with the secondary antibody. 
Finally, a sample of irRBC treated with PHIS and stained with Alexa-488 as well 
as DAPI validated the whole gating process. An example of the gating process 
with the FlowJo software can be seen in Figure 47 (appendix). 
 
Figure 30 Gating strategy of irRBC stained with Alexa-488 
Flow cytometry gating strategy of Alexa-488 positive cells detected in rRBC treated with PHIS from Kelifi, 
Kenya. Rhodamine gate (Rhod) was set with the help of non-infected and non-resealed RBC (RBC). rRBC 
non-infected but stained with DAPI were used for the DAPI gating. The infected rRBC stained with DAPI and 
the secondary antibody were used for the gating of Alexa-488 positive cells. Finally, infected rRBC treated 
with PHIS and stained with DAPI as well as the secondary antibody were used to ensure a proper gating  
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Every experiment contained an internal control with non-infected RBC to ensure 
that antibody binding of the sera was not due to differences in the host cell 
factors e.g. kell factor. The non-infected RBC control never showed any binding, 
indicating that the sera did not react to host cell factors (data not shown). Further, 
another internal control with non-resealed RBC (RBC), which were incubated with 
naïve serum or the PHIS, was included. There was a highly statistically significant 
difference between the relative percentages of Alexa-488 positive cells of RBC 
treated with naïve serum compared to the PHIS sera. The German naïve serum 
was not able to detect infected RBC specified by the relatively low binding of 
~10%. It was expected that there would be differences in the binding of the sera 
for the different rRBC. Indeed, there was a lower binding affinity of the PHIS for 
parasites grown in the HsHsp70K71M however this difference was not statistically 
significant. Taken together, all 3 rRBC samples showed low binding with the 
naïve serum and a significant increase was achieved by the use of the PHIS 
(Figure 31). 
 
Figure 31 Alexa-488 positive cells with Naïve serum and PHIS in rRBC 
Dot blot with boxes of RBC and rRBC, rRBC pre-loaded with HsHsp70
wt
 (HsHsp70
wt
) or with HsHsp70
K71M
 
(HsHsp70
K71M
) incubated with either naïve serum or PHIS from Kelifi, Kenya. Infected RBC and rRBC only 
stained with the secondary antibody acted as background and was always subtracted. Data are shown as 
the relative percentage of Alexa-488 positive cells calculated based on the highest amount of Alexa-488 cells 
for each experiment. The mean values of the 3 independent experiments are indicated by red dashes and 
statistical significance was determined by the One-Way ANOVA-Holm Sidak test. 
 
In the end, the change from the LDH assay to the flow cytometry cleared the 
confusion regarding the effect of HsHsp70 for parasite survival and made results 
much more reliable as well as reproducible. Using flow cytometry it was seen that 
there is no effect of HsHsp70 on the intra-erythrocytic development, but 
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interestingly after 96 h, addition of the HsHsp70wt revealed a positive effect on 
parasite growth. The analysis of the parasite stages displayed a significantly 
lower amount of schizonts after 48 h for parasites grown in the presence of 
HsHsp70K71M compared to the control. Finally, the expression of antigens on the 
surface of the irRBC was unaltered by the presence of the HsHsp70K71M as 
shown by the sera experiments.  
 
3.4 Growth analysis of HsHsp70 in PfHsp70x knockout parasites  
It has been demonstrated that the parasite itself also exports an Hsp70-protein 
called PfHsp70x (from now on referred to as Hsp70x) to the host cell. Recent 
studies did not demonstrate an essential function of Hsp70x regarding the 
parasite development, leading to the assumption that the function of Hsp70x 
might be covered by the host chaperone (Charnaud et al., 2017). As the 
aforementioned analysis of HsHsp70 in the infected erythrocyte did not show any 
essential function of the host chaperone, it was speculated that the function might 
be compensated by the parasite chaperone. To address this hypothesis, it was 
analysed whether parasites depleted of Hsp70x (∆Hsp70x) are able to survive in 
the presence of HsHsp70K71M. The same experimental setup as already 
explained for the wildtype 3D7 parasites was chosen but this time, ∆Hsp70x 
parasites were used. Before starting the growth experiments, it was ensured that 
the used ∆Hsp70x parasites were depleted of Hsp70x by immunoblotting. Indeed, 
∆Hsp70x were lacking Hsp70x compared to a wildtype control (shown in the 
appendix, Figure 48). Afterwards, ∆Hsp70x parasites were MACS purified and 
mixed with rRBC, rRBC with an excess amount of HsHsp70wt or HsHsp70K71M. 
After 48 and 96 h, parasites were fixed with 4% PFA and stained with DAPI 
followed by flow cytometry analysis. The gating was performed as explained in 
Figure 26. As previously mentioned, parasites were treated with BFA acting as a 
positive control for dead parasite, which did not display any relative growth. 
Further, there were no significant differences in the growth of the 3 rRBC after 48 
h. Yet, a significantly increased growth was observed after 96 h in the presence 
of the 2 proteins HsHsp70wt and HsHspK71M compared to the control (Figure 32).  
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Figure 32 ∆PfHsp70x growth in rRBC with HsHsp70
wt
 and HsHsp70
K71M
 
Flow cytometry analysis of ∆Hsp70x parasites grown in rRBC, rRBC with excess of HsHsp70
wt
 or 
HsHsp70
K71M
. Parasites were treated with BFA (50 µg/mL) as a positive control for death. Dot blot with box 
indicates relative growth in percent of 3 independent experiments. The relative growth was calculated based 
on the highest parasitemia in the single assays. Background of non-infected rRBC, HsHsp70
wt
 and 
HsHsp70
K71M
 stained with DAPI were subtracted, respectively. The mean values are indicated by a red dash 
and statistical significance was determined by the One-Way ANOVA-Holm Sidak test. 
 
In the next step, ∆Hsp70 parasites were analysed via SYBR green staining for 
rings/trophozoites and schizonts. The experimental setup, staining as well as 
gating, was performed as previously explained in chapter 3.3. No difference in 
the ring/trophozoite and schizont stages between the 3 rRBC samples was 
observed after 48 h. Although, the power of the performed statistical test was 
below the desired power and in consequence it is less likely to detect a difference 
when one actually exists. After 96 h, statistical significance was determined with 
confidence resulting in no difference in growth for the ring/trophozoite stage of 
rRBC, HsHsp70wt and HsHsp70K71M (Figure 33). It was observed that the 
determined ring/trophozoite numbers displayed big variances and in 
consequences more repeats are needed to validate the data. 
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Figure 33 Analysis of ring/trophozoite and schizont stages in rRBC with HsHsp70
wt
 and HsHsp70
K71M
 
Flow cytometry analysis of ∆Hsp70x parasites grown in rRBC, rRBC pre-loaded with an excess amount of 
HsHsp70
wt
 or HsHsp70
K71M
 for 48 h and 96 h stained with SYBR green. Box blot with box presents relative 
percent of SYBR green positive cells from 3 independent experiments. The relative percent of SYBR green 
positive cells was calculated based on the highest parasitemia in the single assays. Background of non-
infected rRBC, HsHsp70
wt
 and HsHsp70
K71M
 stained with SYBR green were subtracted, respectively. The 
mean values are indicated by a red dash and statistical significance was determined by the One-Way 
ANOVA-Holm Sidak test.  
 
Any potential difference in the surface expression of the ∆Hsp70x infected rRBC 
was analysed using naïve German sera from donors who never acquired 
immunity against malaria and PHIS from the endemic malaria region in Kelifi, 
Kenya. The experiment was performed as explained in chapter 3.3. Additionally, 
an internal positive control of wildtype erythrocytes was incubated with naïve 
serum and the PHIS. The incubation with the PHIS led to a significant increase of 
Alexa-488 positive cells, thereby indicating a correct experimental setup. 
Surprisingly, incubation of infected rRBC, rRBC with HsHsp70wt and 
HsHsp70K71M with PHIS did not display statistically significant differences (Figure 
34).  
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Figure 34 Alexa-488 positive cells with naïve serum and PHIS in rRBC  
Dot blot with box of ∆Hsp70x cultivated in RBC and rRBC, rRBC pre-loaded with HsHsp70
wt
 or HsHsp70
K71M
 
incubated with either naïve serum or PHIS from Kelifi, Kenya. Infected RBC and rRBC only stained with the 
secondary antibody acted as background and were always subtracted. Data are shown as the relative 
percentage of Alexa-488 positive cells, calculated based on the highest amount of Alexa-488 cells for each 
experiment. The mean values of the 2 independent experiments are indicated by a red dash and statistical 
significance was determined by the One-Way ANOVA-Holm Sidak test. 
 
In summary, the use of ∆Hsp70x parasites disclosed no essential function of 
HsHsp70 for parasite survival. Yet again, a positive effect upon the addition of 
HsHsp70wt as well as HsHsp70K71M on the parasite growth after 96 h was 
revealed. Further, no differences in surface expression of the 3 ∆Hsp70x infected 
rRBC were detected.  
 
3.5 Microscopy analysis of known exported proteins in rRBC 
In addition to the performed sera experiments (explained in the chapters 3.4 and 
3.5), the protein export in rRBC was evaluated by microscopy analysis of 2 
exported GFP-tagged proteins. In this regard, rRBC, rRBC pre-loaded with an 
excess of HsHsp70wt or HsHsp70K71M were infected with MACS purified SBP1-
GFP tagged parasites (SBPGFP). The SBPGFP parasites localise to the Maurer’s 
clefts in the infected erythrocyte (Saridaki et al., 2009). 48 h post-invasion, the 
parasites were examined by fluorescence microscopy. The rRBC sample 
revealed export of the fusion protein SBPGFP. The pattern of the fusion protein 
was altered compared non-resealed cells (Saridaki et al., 2009), which might be 
caused by the morphology of the rRBC. Remarkably, the presence of 
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HsHsp70K71M did not block the protein export of SBPGFP to the host cell cytosol 
(Figure 35).  
 
Figure 35 Fluorescent analysis of SBP
GFP
 in rRBC 
Live cell imaging of SBP
GFP
 infecting rRBC (rRBC), rRBC pre-loaded with an excess amount of HsHsp70
wt
 
(HsHsp70
wt
) or HsHsp70
K71M
 (HsHsp70
K71M
). The nucleus was visualised by DAPI. 63x objective 
magnification, DIC: Differential Interference Contrast. 
 
Secondly, the export of a STEVOR-GFP fusion protein (STEVORGFP) to the host 
cell cytosol was analysed by the same experimental setup. STEVOR is a known 
exported protein and localises to the Maurer’s cleft and is associated with 
antigenic variation (Przyborski et al., 2005). The control using rRBC confirmed 
export of the fusion protein, although the localisation appeared slightly different 
compared to wildtype infected erythrocytes (Przyborski et al., 2005), which might 
be due to the altered appearance of the rRBC. Surprisingly, the presence of 
HsHsp70K71M did not inhibit the protein transport of STEVORGFP to the host cell. 
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Figure 36 Fluorescent analysis of STEVOR
GFP 
in rRBC 
Live cell imaging of STEVOR
GFP
 in rRBC (rRBC), rRBC pre-loaded with an excess amount of HsHsp70
wt
 
(HsHsp70
wt
) or HsHsp70
K71M
 (HsHsp70
K71M
). Nucleus was visualised by DAPI. 63x objective magnification, 
DIC: Differential Interference Contrast. 
 
In closing, in both SBP1 and STEVOR infected cells, the pattern looked different 
to non-resealed cells, but there appeared to be no recognisable difference 
between the 3 resealed cell populations. These data imply that the parasite does 
not hijack HsHsp70 for its own purposes and are supporting the obtained data 
from the previous sera experiments.  
 
3.6 Evaluating the function of ovalbumin for the intra-erythrocytic 
development 
It was noted that during the growth analysis of wildtype 3D7 and ∆Hsp70x in 
rRBC, both displayed a significant increased growth profile after 96 h upon 
addition of protein compared to the control rRBC. The 3D7 showed an increased 
growth upon the addition of HsHsp70wt (Figure 27), while the ∆Hsp70x revealed 
an increased growth in the presence of both HsHsp70wt and HsHsp70K71M (Figure 
32). These results raise the possibility that parasites used the added HsHsp70 as 
a nutritional source, leading to a growth advantage. To address this hypothesis, it 
was tested whether the addition of a random protein to the rRBC led to the same 
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positive effect. For this purpose, ovalbumin, a common protein in chicken egg 
white, was pre-loaded to the RBC. First, the pre-loading and entrapment of 
ovalbumin to the erythrocyte was analysed. The immunoblot analysis using an 
anti-ovalbumin antibody revealed that protein uptake during the resealing process 
was achieved (Figure 17A). Further, with a standard consisting of different 
ovalbumin concentrations the exact amount in ng was determined by ImageJ 
quantification, revealing an approximately 28 ng uptake of ovalbumin/107 
erythrocytes. This is in good agreement with the determined 30 ng of 
HsHsp70wt/K71M observed in the previous experiments (Figure 17B). Additionally, 
the haemoglobin amount was determined for rRBC and the rRBC containing 
ovalbumin (Oval) by measuring the absorbance at 570nm. A sample consisting of 
wildtype erythrocytes (non-resealed) was set as 100% and the respective 
percentages for the rRBC samples were calculated accordingly. Both rRBC and 
rRBC pre-loaded with ovalbumin showed 40% haemoglobin compared to 
wildtype RBC (Figure 17C).  
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Figure 37 Immunodetection of ovalbumin in rRBC 
(A) Immunoblot of rRBC (10
7
) pre-loaded with ovalbumin (Resealing 1-3) separated on a 12% SDS gel. A 
standard of different ovalbumin concentrations ranging from 20-100 ng were loaded, as well. Bands 
were visualised with an anti-ovalbumin sera and the size marker in kDa is indicated on the left side. 
Oval: Ovalbumin. 
(B) ImageJ quantification of ovalbumin (Oval) enclosed in rRBC during the resealing in ng/10
7
 RBC. The 
concentration was determined with the help of the standard of 20-100 ng ovalbumin. Bar chart with 
standard deviation shows results of 3 independent resealing reactions.  
(C) Haemoglobin amount in percent of rRBC (rRBC) and rRBC preloaded with ovalbumin (Oval) compared 
to non-resealed wildtype erythrocytes determined with the absorbance at 650 nm. Bar chart with 
standard deviation marks results of 3 independent resealing reactions. 
 
After ensuring that the rRBC were pre-loaded with ovalbumin and equal 
haemoglobin amounts were achieved, the pre-loaded rRBC were used in another 
growth assay, which in contrast to previous experiments also included non-
resealed wildtype erythrocytes. The RBC, rRBC and rRBC with ovalbumin were 
infected with MACS purified 3D7 wildtype parasites. Growth was monitored after 
48 h and 96 h. The parasites were fixed with 4% PFA and stained with DAPI to 
visualise the parasites. Finally, growth was analysed using flow cytometry and 
gating was performed according to Figure 26. There was significant less growth 
observed for the rRBC and rRBC with ovalbumin compared to the RBC after 48 
as well as 96 h. Interestingly, parasites grown in the presence of ovalbumin 
presented a slight increase in growth after 48 h compared to the rRBC, although 
not significantly. Surprisingly, irrelevant of the rRBC pre-loaded with or without 
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protein, parasites showed small relative growth after 96 h, comparable to the BFA 
control samples. However, the addition of ovalbumin caused a small, but 
insignificant difference in growth compared to the rRBC control (Figure 38).  
 
Figure 38 Growth analysis of 3D7 wildtype parasites in rRBC pre-loaded with Ovalbumin 
Flow cytometry assay of 3D7 parasites grown in RBC, rRBC, rRBC pre-loaded with an excess amount of 
ovalbumin (Oval) for 48 h and 96 h. Parasites were treated with BFA (50 µg/mL) as a positive control for 
parasite death. Dot blot with box indicates relative growth in percent of 3 independent experiments. The 
parasitemia of RBC was set as 100%. Background of non-infected RBC, rRBC and rRBC with ovalbumin 
stained with DAPI were subtracted, respectively. The mean values are indicated by a red dash and statistical 
significance was determined by the One-Way ANOVA-Holm Sidak test.  
 
This analysis revealed only a slightly increased growth for rRBC compared to the 
BFA control after 96 h and suggested that parasites cannot propagate efficiently 
in rRBC for 2 full cycles. For this reason, the parasitemia in percent was 
compared between RBC and rRBC. Indeed, parasites grown in the rRBC 
presented lower parasitemia after 48 h and were, compared to the RBC control, 
not able to increase their parasitemia after 96 h (Figure 39).  
 
Figure 39 Parasitemia in rRBC and RBC determined after 48 and 96 h 
3D7 wildtype parasites grown in RBC as well as rRBC for 48 and 96 h. Parasitemia was determined in 
percent by flow cytometry and results of 3 independent experiments with standard deviation is presented. 
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In sum, the ovalbumin experiments did not verify the hypothesis that the addition 
of protein alone had a favourable effect on parasite growth in rRBC. However, 
parasites barely propagate in the rRBC after 48 h.  
 
3.7 Growth analysis of HsHsp70 P. berghei infected human liver cells 
Results so far have not shown an essential function of HsHsp70 for the intra-
erythrocytic development of P. falciparum. Yet, HsHsp70 may still be important 
for other stages of the complex parasite life cycle e.g. the liver stages. To clarify 
whether HsHsp70 is vital to the liver stages of P. berghei, the agent causing 
rodent malaria, a growth analysis was performed. To this end, an HsHsp70 
downregulation using siRNA in the human carcinoma liver cells, HuH7, was 
performed. A siRNA directed against HsHsp70 as well as scrambled RNA 
(negative control) were purchased. First, different concentrations of the siRNA 
and scrambled RNA (scraRNA) were tested and introduced by a lipofectamine 
transfection into the cell. Additionally, a control which was only treated with 
lipofectamine (Mock) and a positive control (PC) were included. The 
downregulation was controlled using immunoblotting against HsHsp70 and 
GAPDH (loading control). In fact, all used siRNA concentrations showed 
downregulation of HsHsp70, while usage of the scraRNA did not lead to a 
downregulation (Figure 40A). The ImageJ quantification determined a good 
downregulation to ~35% of HsHsp70 already with the lowest concentration of 5 
pmole siRNA. At the same concentration the scrambled siRNA revealed no 
downregulation (Figure 40B).  
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Figure 40 HsHsp70 siRNA downregulation in HuH7 cells  
(A) Immunoblot analysis of HuH7 liver cells transfected with different concentrations of siRNA and a control 
scrambled RNA (scraRNA). Bands were visualised with sera directed against HsHsp70 and GAPDH 
acting as a loading control. The mock control was only treated with lipofectamine and the positive 
control (PC) was untreated. The size marker in kDa is indicated on the left side.  
(B) ImageJ quantification of relative HsHsp70 amount in percent from (A). The HsHsp70 amount was 
normalised against GAPDH and the relative HsHsp70 amount was calculated according to the highest 
determined value by ImageJ. Result of 1 experiment is shown.  
 
As 5 pmole siRNA resulted in a downregulation with the cells still appearing 
healthy, this concentration was chosen for all further experiments. The HuH7 
cells were reverse transfected with 5 pmole of either siRNA, scraRNA or were 
only treated with lipofectamine (mock). 48h post-transfection, cells were 
harvested and analysed by immunoblotting for downregulation. Indeed, only a 
faint band for HsHsp70 was detected in cells treated with the siRNA. Both 
controls scraRNA and mock showed presence of HsHsp70 (Figure 41A). An 
ImageJ quantification revealed that only ~20% HsHsp70 remained after the 
siRNA downregulation. In comparison to both controls, the HsHsp70 amount was 
significantly decreased by the siRNA (Figure 41B). To assess the specificity of 
the used siRNA, which was only directed against HsHsp70 and not the cognate 
form HsHsc70, the same samples of HuH7 cells treated with either the siRNA, 
scraRNA or the mock control were examined by immunoblotting against 
HsHsc70. All 3 samples displayed a comparable amount of HsHsc70 and did not 
show a downregulation of HsHsc70 by the siRNA (Figure 41C). The ImageJ 
quantification did not present any downregulation of HsHsc70, as well (Figure 
41D).  
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Figure 41 Amount of HsHsp70 and HsHsc70 in downregulated HuH7 cells 
(A) Immunoblot analysis of HuH7 liver cells transfected with 5 pmole siRNA or a control scrambled RNA 
(scraRNA). Bands were visualised with sera directed against HsHsp70 and GAPDH acting as a loading 
control. The mock control was only treated with lipofectamine and the positive control (PC) was 
untreated. The size marker in kDa is indicated on the left side.  
(B) ImageJ quantification of relative HsHsp70 amount in percent from (A). The HsHsp70 amount was 
normalised against GAPDH and the relative HsHsp70 amount was calculated according to the highest 
determined value by ImageJ. Bar chart with standard deviations shows results of 3 independent 
experiments. The statistical significance was determined by the One-Way ANOVA-Holm Sidak test. 
(C) Immunoblot analysis of HuH7 liver cells transfected with 5 pmole siRNA and a control scrambled RNA 
(scraRNA). Bands were visualised with sera directed against HsHsc70 and GAPDH used as loading 
control. The mock control was only treated with lipofectamine and the positive control (PC) was 
untreated. The size marker in kDa is indicated on the left side.  
(D) ImageJ quantification of relative HsHsc70 amount in percent from (C). The HsHsc70 amount was 
normalised against GAPDH and the relative HsHsc70 amount was calculated according to the highest 
determined value by ImageJ. Results of 3 independent experiments are shown in bar chart with 
standard deviation. The statistical significance was determined by the One-Way ANOVA-Holm Sidak 
test. 
 
Additionally, 48 h post-transfection the downregulated HuH7 cells were infected 
with P. berghei sporozoites. After 2 h, sporozoites that did not infect the liver cells 
were washed away and non-fixed parasite liver stages were analysed 48 h post-
infection by flow cytometry. The used sporozoites expressed GFP under control 
of the CircumSporozoite promoter (CS promoter), while RFP was expressed 
under the elongation factor 1 α (eF1α) promoter. The CS promoter is only active 
till 24 h post-invasion thus, only GFP-expressing liver stages were analysed. 
First, using non-infected HuH7 the gate for GFP positive cells was set. Finally, 
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the gating was controlled by a sample of infected HuH7 cells (Figure 42). An 
example of the whole gating strategy can be seen in Figure 49 (appendix). 
 
Figure 42 Gating strategy for HuH7 cells infected by P. berghei 
Flow cytometry gating strategy of GFP positive cells detected in HuH7 cells. Non-infected HuH7 cells were 
used to set the gate for GFP positive cells (GFP+). The GFP gating was controlled by P. berghei (Pb) 
infected HuH7 cells.  
 
After ensuring a proper gating, the growth of P. berghei liver stages in the HuH7 
downregulated cells was analysed. However, no decrease in growth was 
displayed for a downregulation of HsHsp70 (Figure 43A). Although, the power of 
the performed statistical test was below the desired power and in consequence it 
is less likely to detect a difference when one actually exists, indicating the need 
for more repetitions.  
A flow cytometry analysis enables not only counting of a distinct cell population, 
but also allows comparison of the cell’s size. Therefore, the geometric mean 
acquired from the different cells was compared (Figure 43B). Interestingly, cells 
treated with the scraRNA displayed a significant increase in size.  
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Figure 43 Growth and size of P.berghei in HuH7 cells with downregulated HsHsp70 amount after 48 h 
post-invasion 
(A) Flow cytometry assay of P. berghei parasites in HuH7 treated with lipofectamine (mock), with 5 pmole 
siRNA directed against HsHsp70 (siRNA) or scraRNA (scraRNA) 48 h post-invasion. Dot blot with box 
marks relative growth in percent of 3 independent experiments. The highest parasitemia of each assay 
was set as 100%. Background of non-infected HuH7 was subtracted. The mean values are indicated by 
a red dash and statistical significance was determined by the One-Way ANOVA-Holm Sidak test. 
(B) Analysis of geometric mean determined by flow cytometry (based on A). Dot blot with box indicates 
relative size in percent. The highest geometric mean of the single experiment was set as 100%. The red 
dash symbols statistical significance which was determined by the One-Way ANOVA-Holm Sidak test. 
 
In summary, a specific downregulation of HsHsp70 to ~20% was achieved in 
HuH7 cells. Remarkably, P. berghei did not fail to develop in HuH7 with a 
decreased HsHsp70 amount. In spite of this, more experiments are needed to 
verify the results.  
 
3.8 Conclusion 
This study investigated the role of HsHsp70 in the asexual intra-erythrocytic life 
cycle of P. falciparum. To this end, a resealing method was successfully 
established, which allowed the entrapment of 30 ng pure, untagged HsHsp70wt or 
HsHsp70K71M into the rRBC. The performed growth assay with the 3D7 wildtype 
as well as the ∆Hs70x did not demonstrate an essential function for the 
development of the parasite. However, it was noted that parasites displayed a 
significantly increased growth after 96 h in the presence of excess amounts of 
HsHsp70wt and HsHsp70K71M. Therefore, it was hypothesised that parasites used 
the 2 added proteins as a nutritional source, leading to a growth advantage. 
Nonetheless, experiments with 30 ng ovalbumin entrapped in rRBC did not 
support this hypothesis. Further, the comparison of the growth of RBC with rRBC 
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over 48 and 96 h disclosed that parasites barely propagate after 96 h in rRBC, 
indicating that a great deal of attention must be paid when interpreting the growth 
data after 96 h. Interestingly, first results demonstrated that HsHsp70 was not 
essential for the exo-erythrocytic development of P.berghei. At last, in contrast to 
previous translocation studies, it was not shown that HsHsp70 is involved in 
protein transport to the host cell cytosol.  
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4 Discussion 
To this day, not much is known about the complex mechanisms underlying 
protein trafficking from the parasite to a host cell that lacks any protein transport 
infrastructure (Elsworth et al., 2014). However, it is well established and 
understood that the parasite drastically changes the appearance and the 
biophysical properties of the infected erythrocyte (Cowman et al., 2016; Phillips et 
al., 2017). These host cell modifications are closely related to the disease’s 
pathology and are essential to the survival of the parasite (Cowman et al., 2016; 
Phillips et al., 2017). It was long debated how the parasite-encoded proteins are 
able to cross so many membranes like the PPM, PVM and can even be 
presented on the surface of the infected erythrocyte. In particular, the crossing of 
the PVM was debated intensively (Charpian and Przyborski, 2008). In the end, 
the discovery of the PTEX translocon located in the PVM (de Koning-Ward et al., 
2009) has considerably deepened the knowledge and set the stage for new 
theories. As previously discussed in detail in 1.4.4 a lot of data implicated an 
essential role of HsHsp70 for the intra-erythrocytic development of P. falciparum 
(Alampalli et al., 2018; Ansorge et al., 1996; Banumathy et al., 2002; Charpian, 
2008; Günnewig, 2016; Jha et al., 2017; Külzer et al., 2012) which was analysed 
in this study.  
 
4.1 The role of HsHsp70 for intra-erythrocytic survival of the parasite 
During the maturation the erythrocyte lost classical eukaryotic organelles such as 
the rough ER, Golgi apparatus, mitochondria and the nucleus (Gronowicz et al., 
1984) making the human mature erythrocyte not an easy target for genetic 
manipulations. Consequently, it was not possible to generate erythrocytes that 
are deficient of HsHsp70. Further, the depletion of HsHsp70 e.g. by Co-IP was 
discharged as a possible strategy due the fact that HsHsp70 binds to 
hydrophobic stretches in their client proteins (Rüdiger et al., 1997). The Co-IP 
method might potentially not only result in the deletion of HsHsp70 from the 
human mature erythrocyte, but also significantly reduce the amount of client 
proteins and other chaperones (Berndt, 2014). It is well established that 
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mutations in HsHsp70 are associated with several diseases, such as multiple 
sclerosis, and an increased cancer risk (Boiocchi et al., 2014; Jalbout et al., 
2003; Mestiri et al., 2001). Using the blood of these patients would be an 
alternative to study the effects of HsHsp70 for intra-erythrocytic development of 
P. falciparum. Nonetheless, it would be challenging to collect enough fresh 
material, since the blood cannot be older than 2 weeks as parasites cannot 
multiply efficiently in older cells (Kim et al., 2007). On the other hand, acquiring 
the official permission by the ethics committee to use the blood from patients that 
are already suffering from a disease might be a challenging and time consuming 
process. 
As a result from the lack of options, a resealing or pre-loading process, which 
was used to introduce a dominant negative effect, was chosen to investigate the 
role of HsHsp70 for the intra-erythrocytic development of the parasite. The 
resealing method is widely used in pharmacology (Bourgeaux et al., 2016; 
Magnani et al., 1998, 2002; Rossi et al., 2005). Several test experiments were 
performed before a reproducible method with a sufficient resealing efficiency was 
established. Further, it was ensured that the rRBC were still infected by P. 
falciparum (Figure 13). For the dominant negative effect the HsHsp70K71M mutant, 
which is unable to hydrolyse ATP, was chosen (O’Brien et al., 1996). First, it was 
tested if HsHsp70K71M can be entrapped into the erythrocyte. Indeed, a 5- to 6-
fold increase in HsHsp70K71M compared to rRBC was accomplished (Figure 18). 
Then, the growth of P. falciparum 3D7 parasites in the presence of HsHsp70K71M 
was analysed after 48 and 96 h. Interestingly, the growth after 48 h was not 
affected by the presence of HsHsp70K71M (Figure 27). Also the usage of ∆Hsp70x 
parasites did not display any difference in the growth profile for the presence of 
an excess amount of HsHsp70K71M after 48 h (Figure 32). Notably, both parasite 
strains showed increased growth after 96 h upon the addition of the 2 proteins. 
Therefore, it was hypothesised that the improved growth was caused by 
increased protein amount, which might function as a nutritional source for the 
parasite. This theory was tested by entrapping the same amount of ovalbumin, 
the main protein in chicken egg white, to the erythrocyte using the same protocol 
as for the HsHsp70 proteins (Figure 37). Surprisingly, the addition of ovalbumin 
did not lead to a growth advantage for the parasite (Figure 38). In consequence, 
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the simple addition of more protein does not lead to a growth advantage. Yet, it 
might be that more repeats are needed as so many factors play role in the assay 
and for the growth of the parasite, which might be hiding a statistically significant 
effect. These ovalbumin experiments also included a control of wildtype non-
resealed erythrocytes. The comparison of direct parasitemias after 48 and 96 h in 
erythrocytes and rRBC clearly showed that parasites cannot propagate in rRBC 
after 48 h (Figure 39). Consequently, considerable attention must be paid when 
interpreting the results after 96 h.  
In addition, the different intra-erythrocytic parasite stages were analysed by a 
SYBR green staining. The 3D7 parasites displayed significantly less schizonts 
after 48 h, which would typically come along with a reduced number of ring 
stages after 96 h. However, this effect was not detected after 96 h (Figure 29). An 
explanation for this discrepancy can be found in the number of experiments. For 
the 3D7 strain only 2 independent experiments were performed and showed big 
variations in the determined numbers. Usually, SYBR green staining allows the 
determination of the exact number of merozoites. For this purpose, the 
erythrocyte membrane is permeabilised, followed by an RNase digest and 
subsequent staining. Unfortunately, due to the permeabilisation, the rhodamine 
signal marking rRBC in flow cytometry experiments was lost (data not shown). 
Thus, the experimental setup had to be changed and might not yet be fully 
adjusted to the rRBC. Another pitfall of this experiment is the missing gating 
control for ring/trophozoites and schizonts. Still, the strongest explanation for the 
discrepancy might be found in the already poor survival rate of the parasites in 
rRBC after 96 h. The development of the different stages for the ∆Hsp70x 
parasites was also analysed. In general, 3 independent experiments for the 
∆Hsp70x parasites were conducted and also showed big variations. However, no 
significant differences in the number of ring/trophozoites and schizonts were 
spotted (Figure 33). Although, the SYBR green staining results should be 
interpreted with caution, however, as similar to the DAPI staining, no effect on the 
parasite’s development in the presence of HsHsp70K71M was found. 
There are 2 possible explanations why the presence of HsHsp70K71M did not 
show an effect on the intra-erythrocytic development of the parasite. Either, a 
technical problem with the dominant negative caused the lack of an effect, or 
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HsHsp70 is simply not pivotal to the survival of the parasite in the used 
experimental setup.  
A classical dominant negative effect is achieved by overexpressing a mutated 
gene to such a high extent that the function of the wildtype protein is disrupted by 
the mutated version. This definition was established in 1987 by Herskowitz 
(Herskowitz, 1987). Most studies in the literature use a classical dominant 
negative on DNA basis and introduced a hetero- or homozygote mutation, which 
is overexpressed by the cell, leading to a classical dominant negative effect 
(Millauer et al., 1994; Zhong et al., 2003). Dominant negative mutations on Hsp70 
have mostly been analysed by in vitro systems such as refolding and ATPase 
assays containing only few partners (Arakawa et al., 2011; Fontaine et al., 2015; 
O’Brien et al., 1996; Szabo et al., 1994). In this study, a classical dominant effect 
was introduced in a cell system and it is possible that the behaviour of the 
dominant negative might be different in this more complex system. However, 
some studies used HsHsc70 and HsHsp70 dominant negative mutations to 
assess their functions in in vivo systems and revealed no loss of function 
(Fontaine et al., 2015; Lagaudrière-Gesbert et al., 2002; Newmyer and Schmid, 
2001).  
Yet, sometimes these classical dominant negatives can also be without an effect 
as seen for a study published by Abraira and colleagues (Abraira et al., 2010). In 
this study, it was elucidated whether a mutated receptor tyrosine kinase ErbB is 
associated with the loss of Netrin-1 expression, a factor essential for the canal 
formation of the inner ear. A classical dominant negative was achieved by 
expressing a mutated ErbB from a virus that infected a chicken embryo (Abraira 
et al., 2010). Interestingly, in contrast to in vitro experiments that closely 
associated non-functional ErbB signalling as the cause of malformations of the 
inner ear canal, the in vivo overexpressed ErbB mutant did not alter the formation 
of the chicken inner ear canal (Abraira et al., 2010). Consequently, Abriaira and 
colleagues were not able to exclude that the low amount of remaining wildtype 
ErbB is enough to ensure proper signalling (Abraira et al., 2010). This would also 
provide a suitable explanation why HsHsp70K71M did not show any effect on 
parasite growth.  
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The amount of residual endogenous HsHsp70 might be enough to provide the 
driving force for the translocation of essential parasite-encoded proteins. For the 
resealing assay a 5- to 6-fold excess amount of the mutant HsHsp70K71M was 
introduced into the cell to disrupt or interfere with the function of the endogenous 
HsHsp70. A similar amount of HsHsp70K71M presented a repressing effect in a 
previous translocation study and indicated a functional dominant negative effect 
(will be discussed in more detail in 4.2). In consequence, since the same amount 
of HsHsp70K71M already blocked the function of the endogenous HsHsp70 in the 
translocation assay, it is tempting to speculate that a similar effect should be 
achieved in the rRBC.  
The fact that there are lots of publications associating HsHsp70 with the transport 
of parasite-encoded proteins (reviewed in 1.4.4) led to the assumption that 
HsHsp70 might be essential to the parasite survival. Since the chaperone system 
is such an important system to the well-being of a cell, it cannot be ruled out that 
other chaperones might compensate for the dominant negative effect. Many other 
chaperones can be found in the erythrocyte e.g. HsHsc70, HsHsp90, HsHsp60 
(TRiC) and PfHsp70x (D’Alessandro et al., 2010; Külzer et al., 2012). All those 
chaperones have overlapping functions and might compensate for the blocked 
HsHsp70 and would thereby ensure the survival of the parasite.  
During the study the survival of ∆Hsp70x parasites in the presence of an excess 
amount of HsHsp70K71M was investigated, as well. Since, Hsp70x is the only 
parasite-encoded and exported chaperone in the host cell (Külzer et al., 2012) it 
would be an excellent candidate for compensation. Most strikingly, Hsp70x is 
only expressed in P. falciparum and P. reichenowi (infecting chimpanzee), 
representatives of the Laveranian species (Külzer et al., 2012). In particular, 
Laveranian species are known to cause more lethal malaria forms by 
cytoadhering to the vascular endothelium (Charnaud et al., 2017). First, it was 
speculated that Hsp70x might be essential for the parasite’s survival due to its 
special link to the Laveranian species. However, Hsp70x depletion in vitro was 
not lethal to P. falciparum and only smaller effects on the export of EMP1, 
thereby reducing cytoadherence, were detected (Charnaud et al., 2017). In 
consequence, it might be that protein transport in ∆Hsp70x parasites was 
assisted by HsHsp70. Nevertheless, the blockage of HsHsp70 by the dominant 
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negative version and usage of the ∆Hsp70x parasites did not display a growth 
defect.  
Another possible candidate is the cognate form HsHsc70. It is possible that the 
wrong Hsp70 was investigated in this study. In particular, the pulldown assay 
performed with components of the PTEX translocon point towards HsHsc70. 
Here, HsHsc70 was found to be 6-fold enriched at the translocon, which is highly 
indicative for a role in the transport of parasite-encoded proteins (de Koning-
Ward et al., 2009). However, other studies e.g. Zhang and colleagues found 
HsHsp70 to be a member of the J-dot chaperone complex, which is closely 
associated with the transport of EMP1 (Külzer et al., 2012, 2010; Zhang et al., 
2017). Moreover, a study using HsHsp70K71M did efficiently block the transport of 
a parasite-encoded protein (Günnewig, 2016).  
An additional interesting candidate for a role in the transport of parasite encoded 
proteins can be assigned to HsTRiC. Batinovic and colleagues found HsTRiC as 
well as HsHsp90 to be associated with EMP1. Hence, it was proposed that EMP1 
trafficking and folding is performed by these human chaperones (Batinovic et al., 
2017). 
Apart from the experiments in P. falciparum also P. berghei, the Plasmodium 
species causing malaria in rodents, was investigated. Most strikingly, HsHsp70 
was also dispensable for the development of the exo-erythrocytic liver stages 
(Figure 43A). However, HuH7 cells were stressed by the lipofectamine treatment 
indicated by lots of cell debris (see appendix Figure 49). Usually, the infection is 
additionally analysed and quantified by fluorescence microscopy. Here, HuH7 
were infected with GFP-labelled sporozoites allowing an easy analysis. By flow 
cytometry a high parasitemia was detected in all samples, which was confirmed 
from first glances. Further, in accordance with the determined numbers by flow 
cytometry, HsHsp70 downregulated cells did not present fewer parasites, but due 
to time restrictions no quantification was performed. Notably, HsHsp70 was 
reduced to ~20% by siRNA addition (Figure 41B). As a result, it cannot be 
excluded that the residual HsHsp70 is sufficient to ensure the survival of the 
parasite. Furthermore, it is possible that the reduction in the HsHsp70 
concentration led to an increased HsHsc70 expression. Indeed, the HsHsc70 
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amount was slightly elevated in the siRNA treated cells, but not significantly 
(Figure 41D). In general, the HuH7 experiments did not reveal an essential role in 
parasite survival, although a completely different stage of the parasite’s life cycle 
and even a different parasite species were investigated. In the end, further 
experiments are needed to secure the phenotype.  
Altogether, chaperones might be such a redundant system that it might be 
challenging to block protein folding and trafficking by interfering with one 
chaperone to provoke a fatal outcome. As seen for ∆Hsp70, the parasite might 
sometimes survive, despite the protein transport being altered (Charnaud et al., 
2017), which was also investigated in this study. 
 
4.2 HsHsp70 and its role in protein transport across the PVM 
Apart from the role of HsHsp70 for the survival of the parasite, it was also 
investigated whether HsHsp70 is essential to the export of parasite-encoded 
proteins to the host cell. A previously mentioned study conducted by J. Günnewig 
used a complex translocation assay to investigate the role of HsHsp70 for protein 
transport using a classical dominant negative assay (Günnewig, 2016). Briefly, 
mid-stage trophozoites were subjected to a tetanolysin permeablisation, leading 
to the lysis of the erythrocyte membrane, while the PVM and PPM were still 
intact. Afterwards, the host cell cytosol was removed by intensive washing and 
finally the permeabilised trophozoites were placed in a medium containing host 
cell cytosol of non-infected erythrocytes, which was enriched with an excess 
amount of the HsHsp70K71M. Then, the translocation process of the marker 
protein GBP130 across the PVM was followed. This approach was successfully 
used to obtain the first experimental data that HsHsp70 is essential for the 
translocation of GBP130. In this study, the presence of HsHsp70K71M did not 
affect the protein export as shown by sera experiments using neither the wildtype 
3D7 parasite nor the ∆Hsp70x parasites (Figure 31 and Figure 34). Further, 
microscopic analysis of the export of STEVORGFP and SBPGFP was negative 
(Figure 35 and Figure 36). There are several explanations for the discrepancies 
between the translocation data and the findings of this study.  
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As previously stated and discussed in detail in 4.1, the dominant negative assay 
has major drawbacks concerning its efficiency. However, already for the 
translocation assays a similar amount of HsHsp70K71M was added to host cell 
cytosol as for the resealing assays. In the end, both experiments used a 5- to 6-
fold excess of HsHsp70 compared to the respective assay controls (Figure 18C). 
Thereby indicating that the used amount of HsHsp70K71M entrapped in the rRBC 
should be enough, since the translocation assay clearly showed an effect, which 
is in favour of a functional dominant negative effect and weakens the hypothesis 
of a technical malfunction during the assay.  
However, the used resealing assay is accompanied with other technical 
challenges. In general, if the protein transport is affected by the dominant 
negative, the infected erythrocyte’s cytoadherence capability as well as its rigidity 
can be altered. Mostly, these changes are investigated by classical 
cytoadherence or artificial spleen assays. Due to the fragile nature of the rRBC 
neither of the 2 methods were available. As an alternative, infected rRBC were 
incubated with PHIS from the malaria-endemic area (Kelifi, Kenya) to detect 
differences in the surface expression. Interestingly, neither the use of wildtype 
parasites nor ∆Hsp70x parasites grown in the presence of HsHsp70K71M blocked 
the surface expression of malaria antigens (Figure 31 and Figure 34). Today, it is 
well-established that the immune sera can already identify early exported surface 
proteins, including antigens like RESA (Ring-infected Erythrocyte Surface 
Antigen) (Coppel et al., 1984) and the major virulence factor EMP1 (Beeson et 
al., 2006; Chan et al., 2014). It is therefore assumed that the sera experiments 
performed in this study were suitable to detect a potential differential surface 
expression of the major virulence factor EMP1. However, the results presented 
here, indicate that HsHsp70 is not associated with EMP1 trafficking. 
In addition to the sera experiments, a microscopic analysis using GFP-labelled 
SBP1 and STEVOR was conducted (Figure 35 and Figure 36). In agreement with 
the sera experiments, the transport of both GFP-labelled proteins was not 
affected by the presence of the HsHsp70K71M. One explanation for the 
discrepancies between the translocation and resealing assays, regarding the 
involvement of HsHsp70, might be found in the nature of the assays. In the 
translocation assay the cells are treated with cycloheximide, which blocks the 
Discussion 
91 
parasite’s protein biosynthesis, causing the parasite’s death. The “dead” 
parasites are placed in medium containing the cell lysate of a non-infected cell. 
The rRBC with an excess amount of HsHsp70K71M resembles the in vivo situation 
more closely and can sustain parasite propagation and survival for at least one 
complete cycle. In theory and in practice, the parasite is able to export proteins to 
the resealed host cell since the parasite relies on this protein trafficking and can 
survive in rRBC. In consequence, in the rRBC Hsp70x might be exported, which 
might compensate for the presence of the mutated HsHsp70K71M. Interestingly, 
usage of the ∆Hsp70x parasites did not show any difference in the surface 
expression of the HsHsp70K71M, as well. Since Hsp70x is so far the only parasite-
encoded and exported chaperone to the host cell, this does not favour the strain 
of argumentation. However, it is still possible that thus far unidentified parasite-
encoded and exported chaperones are involved in the transport. The experiments 
using rRBC have a higher similarity to the in vivo situation than the translocation 
assay and involve a more complex environment, which presumably caused the 
different outcomes in these 2 assays. 
Finally, in the translocation assays a single marker protein for export was 
analysed. GBP130 is a non-essential exported protein and carries a PEXEL motif 
(Grüring et al. 2012). The protein was not included in the analysis of the sera 
experiments or the microscopic assay. Some proteins require the assistance of 
several chaperones in a random or sometimes also ordered process. One 
example is the von-Hippel-Lindau (vHL) protein, a well-studied tumour 
suppressor. For the functional vHL even a tight progression of chaperones is 
pivotal (Melville et al., 2003). First, this protein has to be folded by HsHsp70, 
before TRiC can carry out additional modifications and create the functional vHL 
protein (Melville et al., 2003). Thus, it is possible that GBP130 requires only 
HsHsp70, while the investigated EMP1, SBP1 and STEVOR need help of a 
whole multi-chaperone system which is redundant. Preliminary data obtained 
during the translocation study indicated that HsHsp70 might be only associated 
with the transport of GBP130, as the export of Hsp70x was analysed revealing 
trafficking to the host cell despite the presence of HsHsp70K71M (personal 
communication J. Günnewig and J. Przyborski). Consequently, no effects would 
be detected for the investigated proteins (STEVOR, SBP and EMP1) by the 
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presence of HsHsp70K71M and potential effects on GBP130 were missed as this 
protein was not analysed. 
In general, it is hard to compare the results of the resealing and the translocation 
assays. A final conclusion regarding the involvement of HsHsp70 for the protein 
trafficking is impossible to draw. The HsHsp70 might be assisting in the transport 
to a certain extent, but at least according to the assays used in this study, is not 
essential for transport of parasite-encoded proteins into the host cell.  
 
4.3 HsHsp70 localisation in the non-infected and infected erythrocyte 
During the last 10 years, several efforts failed to localise HsHsp70 in the non-
infected as well as infected erythrocyte using classical immunofluorescence 
assays (personal communication J. Przyborski). Consequently, in this study 
HsHsp70wt was fluorescently labelled with Oregon green and subsequent pre-
loading to the erythrocyte was used to visualise HsHsp70-Oregon green. In the 
non-infected rRBC, HsHsp70-Oregon green displayed mobile foci throughout the 
whole erythrocyte (Figure 20). The experimental setup included 2 controls; (i) 
BSA labelled with Oregon-green, and (ii) the dye itself. Both controls presented 
an equal fluorescence spread all over the cytosol (Figure 20). Interestingly, 
HsHsp70 usually shows an equal distribution in the cell cytosol of various human 
cell types as advertised on the webpages of several commercial antisera vendors 
(e.g. Abcam, Santacruz) and not as mobile foci. However, due to the controls’ 
localisation, it is likely that HsHsp70 might indeed localise as mobile foci in the 
non-infected erythrocyte, even though such a localisation is rather rare. 
Unfortunately, the localisation studies in the infected rRBC using Cy2 labelling of 
the purified HsHsp70wt were not satisfying. In the infected rRBC, HsHsp70wt-Cy2 
revealed an unexpected signal inside the parasite (Figure 21). During the course 
of the study it was noted that the previously cytosolic rhodamine signal presented 
a strong fluorescence inside the parasite particularly in the trophozoite stage. It is 
known that the parasite uses the host haemoglobin in the cytosol as a nutritional 
source (Kamchonwongpaisan et al., 1997). Therefore, the PPM creates 
invaginations to endocytose the host cytosol and the endosome finally fuses with 
the parasite’s food vacuole (Aikawa et al., 1966; Slomianny, 1990). Thus, it was 
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hypothesised that the parasite probably internalised the rhodamine as well as the 
HsHsp70-Cy2, leading to the fluorescence inside the parasite, which indicates 
the food vacuole. The observed co-localisation for the hemozoin and rhodamine 
(Figure 21) strongly supports this theory. Although, another possible explanation 
would be that the dye was released from HsHsp70 and internalised. On the other 
hand, it is feasible that the dye diffused across the membranes and finally got 
trapped in the food vacuole. 
As a dead end was reached to localise HsHsp70 in the infected erythrocyte by 
the fluorescently labelling and pre-loading of the erythrocytes, another approach 
was introduced. The parasite was genetically modified to express and export 
HsHsp70 to its host cell. Therefore, a fusion protein consisting of the first 80 
amino acids of the STEVOR protein, which are sufficient to direct any protein to 
the host cell cytosol, an mCherry tag, and finally the full HsHsp70 amino acid 
sequence was expressed in the parasite. Most strikingly, HsHsp70mCherry 
displayed the same dot-like mobile structures in the infected erythrocyte (Figure 
23) as obtained by the Oregon-green and Cy2 labelled HsHsp70 in the non-
infected erythrocyte (Figure 20 and Figure 21 respectively). Therefore, it was 
analysed whether HsHsp70 co-localises to known dot-like structures in the 
infected erythrocyte, such as the Maurer’s clefts marker SBP1 and J-dot marker 
Hsp70x. For the Maurer’s cleft marker no co-localisation with HsHsp70mcherry was 
observed (Figure 24). In general, Maurer’s clefts consist of more than one protein 
e.g. MAHRP (Maurer’s clefts-Associated Histidine-Rich Protein) is another well-
known member (Spycher et al., 2006). As a result, it cannot be ruled out that 
HsHsp70 is not co-localising with other Maurer’s cleft components. Albeit, SBP1, 
due to its essential role in EMP1 trafficking (Cooke et al., 2006), would be a 
suitable interaction partner for a chaperone. 
Further, it has to be taken into consideration that the tagging of a protein 
sometimes leads to a miss-localisation of the protein of interest (Hanson and 
Ziegler, 2004; Skube et al., 2010), which would have falsified the localisation of 
HsHsp70mCherry. In addition, the parasite is expressing and exporting a foreign 
human protein. Therefore, the parasite might simply lack the requirements to 
ensure the proper function, thereby affecting the chaperone’s activity. Yet, the 
most important limitation lies in the N-terminal position of the tag. HsHsp70 reacts 
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very sensitively to the N-terminal localisation of the tag, which affects its N-
terminal SBD domain, leaving the chaperone inactive (personal communication 
Prof. Dr. Mayer). As a result, due to the mCherry tag, HsHsp70 is non-functional 
and therefore, may be miss-localised. Still, a study conducted by Zeng and 
colleagues used N-terminal GFP-tagged HsHsp70 to localise the protein in non- 
and heat-shocked HeLa cells (Henrietta-Lacks, cervix carcinoma cells) (Zeng et 
al., 2004). The HsHsp70GFP fusion protein displayed a normal cytosolic 
localisation in the control cells (Zeng et al., 2004), indicating that even the 
inactive HsHsp70mCherry protein might be properly localised. In favour are the 
obtained co-localisation data of HsHps70mcherry with Hsp70x which revealed a 
partial co-localisation (Figure 24). This partial co-localisation is supported by a 
proteomic study conducted by Zhang and colleagues disclosing that HsHsp70 
forms a complex with PFE55 (PfHsp40) and Hsp70x (Zhang et al., 2017). 
Further, yeast-two hybrid screens identified HsHsp70 as a promising interaction 
partner for J-dot proteins (Jha et al., 2017).  
During the course of this study, several other approaches like immunoelectron 
microscopy and transiently expressing GFP-labelled HsHsp70 in HuH7 cells 
followed by P. berghei infection were tested (data not shown). Unfortunately, 
none were successful. In the literature several studies found HsHsp70 in various 
localisations, but most strikingly all those studies identified HsHsp70 by classical 
biochemical methods such as Co-IPs and proteomics (Banumathy et al., 2002; 
Jha et al., 2017; Zhang et al., 2017). The latest literature searches for a 
microscopy study of HsHsp70 in the infected host cell were negative, outlining 
the possibility that this might be a demanding task.  
In the future, the deeper understanding of new stem cell technologies and usage 
of newly developed genetic tools can be exploited to localise HsHsp70 in the 
mature human infected erythrocyte. First steps towards this approach were 
already made towards the end of this study and collaboration with the stem cell 
expert Prof. Egan at the Stanford University was established. With the help of 
Prof. Egan, a CD34+ stem cell can be infected with a genetically modified 
lentivirus, thereby inserting a copy of HsHsp70GFP to the stem cell’s chromosome 
(Bei et al., 2010; Egan, 2018; Giarratana et al., 2005). Finally, with the help of 
stem cell factors like erythropoietin, these modified stem cells can be 
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differentiated into mature erythrocytes, a time and cost-intensive process. 
Subsequently, these cells can be infected with P. falciparum. Unfortunately, the 
first experiments were challenging due to a strong auto-fluorescence of the 
differentiated cells (personal communication J. Przyborski). In consequence, no 
conclusion was drawn on the localisation of HsHsp70 in the non-infected or 
infected erythrocyte.  
In closing, more research is needed to finally resolve the localisation of HsHsp70 
and to gain further information about its role in the transport of parasite-encoded 
proteins.  
 
4.4 Outlook 
In this study, a resealing approach was successfully established to introduce a 
classical dominant effect by adding an excess amount of mutated HsHsp70K71M 
to the mature human erythrocyte. Unfortunately, under the given experimental 
setup, the data did not show any growth defect in the presence of the 
HsHsp70K71M. Based on the previously mentioned drawbacks of the resealing 
method e.g. the chance that the dominant negative effect was not achieved or 
simply does not work efficiently in the used experimental setup. Clearly an 
approach to validate the inhibitory effect of HsHsp70K71M is needed. First 
experiments to determine the folding capacity of haemoglobin depleted 
erythrocyte cytosol with luciferase refolding assays were challenging and need 
further development (data not shown). In general, also other mutated HsHsp70 
e.g. D10A, K77Q, K77R, D199A (Arakawa et al., 2011; Seo et al., 2016) could be 
tested. 
Nonetheless, another method is needed to validate the results. In the future, the 
previously explained stem cell approach can also be used to investigate the 
function of HsHsp70 for the intra-erythrocytic development of the parasite. By the 
means of a small hairpin RNA, introduced by a lentiviral transfection, the 
HsHsp70 can be downregulated and cells can be differentiated (Bei et al., 2010; 
Egan, 2018; Giarratana et al., 2005). The HsHsp70 is not identified as an 
essential factor for the differentiation and maturation of the cells (personal 
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communication E. Egan). Further, the method can be used to knock-down other 
known chaperones such as HsHsp90, 60 and 40. Unfortunately, HsHsc70 is 
essential to the differentiation and therefore, cannot be analysed by this system 
(personal communication E. Egan). For the investigation of HsHsc70 the 
resealing approach might come in handy. It is possible to purify a mutated 
HsHsc70K71M and pre-load erythrocytes with an excessive amount. Further, the 
stem cell approach is rather time- as well as cost-intensive and different hairpin 
RNAs have to be tested for efficiency before reliable data can be collected. 
Therefore, the resealing approach might be a good supplement to the performed 
stem cell experiments. In addition, also other purified proteins can be pre-
evaluated using the resealing approach and combinations of different proteins 
such as a dominant negative phenotype for e.g. HsHsc70 and HsHsp90 could be 
introduced. Moreover, the presence of HsHsp70K71M can still result in abnormal 
knobs, an altered cytoadherence or rigidity. Regrettably, the analysis of the 
cytoadherence and rigidity is more than challenging with the rRBC. During the 
course of the study, it was noted that rRBC reacted more sensitive to fixation as 
classical giemsa staining failed to visualise infected erythrocytes. Cytoadherence 
as well as rigidity analysis often involves parasite enrichment with MACS or 
gelafundin, which could be due to fragile nature of rRBC more than challenging. 
However, irRBC could be sorted by Fluorescence Activated Cell Sorting (FACS) 
and afterwards fixed. With the help of Scanning Electron Microscopy (SEM) the 
knobs of the irRBC could be visualised and compared.  
Additional studies with the translocation assays introduced by J. Günnewig 
should be used to analyse and narrow down the minimal host cell chaperone 
system involved in protein transport. Besides, other marker proteins should be 
used to validate that HsHsp70 is indeed not only involved in the transport of 
GBP130, but also targets other proteins. Furthermore, the establishment of 
parasites expressing GFP-labelled exported proteins e.g. the PNEP EMP1 might 
be used to infect the different rRBC with HsHsc70, HsHsp70, 90, 60 and 40 
followed by an analysis of the effect of these chaperones on the transport of 
different proteins.  
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For the localisation of HsHsp70, the previously explained stem cell approach 
should be pursued. In general, further research is needed to analyse the role of 
HsHsp70 for the intra-erythrocytic development of the parasite. 
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Figure 44 Immunoblotting to test antibody specificity of Hsp70 and Hsc70 
Recombinant HsHsp70 and HsHsc70 were separated on a SDS gel followed by immunoblotting using sera 
directed HsHsp70 and HsHsc70. Size marker in kDa is indicated on left side. 
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Figure 45 Gating example: DAPI positive cells in rRBC 
Flow cytometry gating strategy of DAPI positive cells detected in rRBC. First, all cells were displayed in the 
Side SCatter (SSC), indicating the granularity of the cells, versus the Forward SCatter (FSC), measuring the 
size of the cells. From this population, the single cells were gated with the help of setting the SSC-Area (SSC-
A) against the SSC-Height (SSC-H). Afterwards, the gate was set where rhodamine positive cells were 
expected by the SSC-A vs the 561-CA laser with the help of a sample of wildtype non-infected RBC (RBC). A 
sample with rRBC that were non-infected, but stained with DAPI was used to confirm the rhodamine gate and 
to set the gate for the DAPI positive cells using the SSC-A vs the 405-B-H laser (rRBC DAPI). At last, the 
gating process was checked by infected rRBC which were stained with DAPI (irRBC DAPI). SSC: Side 
SCatter, FSC: Forward SCatter, A: Area, H: Height, Rhod_pos: Rhodamine positive cells, DAPI_pos: DAPI 
positive cells. 
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Figure 46 Gating example: SYBR green positive cells in rRBC 
Flow cytometry gating strategy of SYBR green positive cells detected in rRBC to differentiate single-nucleated 
ring/trophozoites (RT) and multi-nucleated schizonts (S). Again, all cells, single cells and rhodamine positive 
cells were gated as described in Figure 45. This time, non-infected and SYBR green stained rRBC were used 
set the gates for the ring/trophozoite stage (RT) and the schizont stage (S) exploiting the SSC-A vs the 488-
BA laser. Unfortunately, no control of a synchronised schizont and mixed ring/trophozoite culture grown in the 
rRBC were used in this experimental setup, therefore gates for the ring/trophozoite and schizont stage had to 
be assumed based on experience. Finally, a sample of infected rRBC stained with SYBR green (iRBC SYBR 
green) was used to control all set gates. SSC: Side SCatter, FSC: Forwards SCatter, A: Area, H: Height, 
Rhod_pos: Rhodamine positive cells, RT: Ring/Trophozoit, S: Schizont. 
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Figure 47 Gating example of irRBC stained with Alexa-488 
Flow cytometry gating strategy of Alexa-488 positive cells detected in rRBC treated with PHIS from Kelifi, 
Kenya. First as previously explained, from all cells the single cells were gated (Figure 45). Rhodamine gate 
was set with the help of non-infected and non-resealed RBC (RBC). rRBC non-infected but stained with DAPI 
(rRBC DAPI) were used for the DAPI gating. A sample of infected rRBC stained by DAPI and incubated with 
the secondary antibody (irRBC DAPI 2nd AB) was used to set the gate of the Alexa-488 positive cells. Finally, 
infected rRBC treated with PHIS and stained with DAPI as well as the secondary antibody (irRBC DAPI PHIS 
2
nd
 AB) were used to ensure a proper gating. SSC: Side SCatter, FSC: Forward SCatter, A: Area, H: Height, 
Rhod_pos: Rhodamine positive cells, 2
nd
 AB: secondary antibody (anti-human Alexa-488), PHIS: (Pool of 
HyperImmune Sera from Kelifi, Kenya). 
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Figure 48 Immunoblotting against Hsp70x 
3D7 and Hsp70x (70x) parasites (10
7
 iRBC) were separated on a SDS gel followed by immunoblotting against 
Hsp70x, and aldolase as a loading control. Size marker in kDa is indicated on left side. 
 
 
 
 
Figure 49 Gating example: HuHu7 cells infected by P. berghei 
Flow cytometry gating strategy of GFP positive cells detected in HuH7 (liver carcinoma) cells. First, from all 
cells displayed in SSC-A vs FSC-A, single cells were gated using the SSC-A vs SSC-H. Non-infected HuH7 
cells were used to set the gate for GFP positive cells (GFP pos). The GFP gating was controlled by infected 
HuH7 cells. Notably, lots of cell debris was seen (arrow), indicating that cells died during the experiment. Most 
likely cells died due to the lipofectamine, since irrelevant of the treatment (e.g with siRNA, scraRNA or only 
lipofectamine) equal amounts of cell debris can be found in all samples (data not shown) SSC: Side SCatter, 
FSC: Forward Scatter, GFP pos: GFP positive cells. 
 
 
